Madhukar Trivedi, M.D.: Psychiatry | UT Southwestern Medical Center

Madhukar Trivedi, M.D.: Psychiatry | UT Southwestern Medical Center
Madhukar Trivedi,
M.D.
Peter O'Donnell Jr. Brain Institute
Betty Jo Hay Distinguished Chair in Mental Health
Julie K. Hersh Chair for Depression Research and Clinical Care
Psychiatry
Biography
Madhukar H. Trivedi, M.D.,
is a Professor in the
Department of Psychiatry
at UT Southwestern Medical Center. He serves as Chief of the Division of Mood Disorders and the founding Director of the Center for Depression Research and Clinical Care, where he holds the Betty Jo Hay Distinguished Chair in Mental Health and the Julie K. Hersh Chair for Depression Research and Clinical Care. He specializes in treating
depression
Dr. Trivedi earned his medical degree at Baroda Medical College in India, where he also completed a residency in
psychiatry
. He performed a second residency in psychiatry at Henry Ford Hospital in Detroit, Michigan, and received advanced training in functional brain imaging and psychopharmacology through a research fellowship at UT Southwestern.
Certified by the American Board of Psychiatry and Neurology, Dr. Trivedi joined the UT Southwestern faculty in 1993.
Dr. Trivedi is an internationally recognized translational researcher focusing on developing and validating biosignatures of depression. He also conducts research on pharmacological, psychosocial, and nonpharmacological treatments for depression. He has been a principal investigator on numerous translational research projects as well as clinical trials; has authored more than 500 peer-reviewed scholarly articles, numerous abstracts, and book chapters; and has delivered more than 200 invited lectures. He serves on the editorial board of
CNS Spectrums
Clinical Medicine: Psychiatry
Journal of Clinical Psychiatry
Journal of Affective Disorders
Psychiatric Annals
and
Asian Journal of Psychiatry
. He is an ad hoc reviewer for several journals.
Dr. Trivedi is President of the American Society of Clinical Psychopharmacology and a member of numerous other professional organizations, including the American College of Neuropsychopharmacology, the American College of Psychiatrists, the American Medical Association, the American Psychiatric Association, the Dallas County Medical Society, the Society of Biological Psychiatry, the Texas Medical Association, and the Texas Society of Psychiatric Physicians.
He has been named a
Texas Monthly
Super Doctor multiple times, including in 2018, and has received numerous local and international accolades, including the Gerald L. Klerman Award from the National Depressive and Manic-Depressive Association Scientific Advisory Board, the Psychiatric Excellence Award from the Texas Society of Psychiatric Physicians, the Gerald Klerman Senior Investigator Award, the American Psychiatric Association Award for Research, and the Mood Disorders Research Award from the American College of Psychiatrists. Dr. Trivedi was listed by Thomson Reuters’ World’s Most Influential Scientific Minds as one of the nation’s most highly cited researchers in psychiatry in 2014, 2015, 2017, and 2019.
Education & Training
Residency -
Henry Ford Health Systems
(1986-1990)
, Psychiatry
Medical School -
Baroda Medical College
(1976-1980)
Internship -
S.S. General Hospital
(1980-1981)
, Psychiatry
Residency -
University General Hospital
(1982-1985)
, Psychiatry
Fellowship -
UT Southwestern Medical Center
(1990-1993)
, Psychiatry
Professional Associations & Affiliations
ACNP American College of Neuropsychopharmacology
American Psychiatric Association
Texas Medical Association
Texas Society of Psychiatric Physicians
Honors & Awards
D Magazine Best Doctor
2025
Outstanding Academician Award
2005
, Indo American Psychiatric Association (IAPA)
Honorary International Advisory Member
2002
, The Chinese Pharmacology Algorithm Project
Psychiatric Excellence Award
2002
, Texas Society of Psychiatric Physicians (TSPP)
Gerald L. Klerman Young Investigator Award
2000
, National Depressive and Manic-Depressive Association Scientific Advisory Board
Depression Specific Content Expert, Evidence Based Report Center (San Antonio)
1997
, Agency for Health Care Policy and Research , U.S. Dept of Health and Human Services
Books & Publications
Publications
Problematic social media use and relationship to mental health characteristics in youth from the Texas Youth Depression and Suicide Research Network (TX-YDSRN)
Betsy D. Kennard, Jennifer L. Hughes, Abu Minhajuddin, Sophia M. Jones, Manish K. Jha, Holli Slater, Taryn L. Mayes, Eric A. Storch, Jacquelyn M. LaGrone, Sarah L. Martin, Jessica L. Hamilton, Rebecca Wildman, Shamari Pitts, Joseph C. Blader, Blake M. Upshaw, E'Lenya K. Garcia, Sarah M. Wakefield, Madhukar H. Trivedi
Journal of Affective Disorders
2025
Characterizing Measurement-Based Care in the Texas Youth Depression and Suicide Research Network (TX-YDSRN).
Slater H, AlZubi Y, Rezaeizadeh A, Hughes JL, Gorman A, Mayes TL, Elmore JS, Storch EA, Wakefield SM, Trivedi MH,
Child psychiatry and human development
2024 Feb
Treatment of Adolescent Depression: Comparison of Psychiatric and Pediatric Settings at an Academic Medical Center Using the VitalSign
Application.
Ayvaci ER, Minhajuddin A, Elmore JS, Yagnik K, Jha MK, Emslie GJ, Mayes TL, Trivedi MH,
Journal of child and adolescent psychopharmacology
2024 Jan
Predicting suicidal events: A comparison of the Concise Health Risk Tracking Self-Report (CHRT-SR) and the Columbia Suicide Severity Rating Scale (C-SSRS).
Mayes TL, Carmody T, Rush AJ, Nandy K, Emslie GJ, Kennard BD, Forbes K, Jha MK, Hughes JL, Heerschap JK, Trivedi MH,
Psychiatry research
2023 Jun
326
115306
Psychometric properties of Concise Associated Symptom Tracking (CAST) scale in youths and young adults: Findings from the Texas youth depression and suicide research network (TX-YDSRN).
Jha MK, Minhajuddin A, Slater H, Mayes TL, Blader J, Brown R, Garza C, Kennard BD, Riddle D, Storch EA, Shotwell J, Soutullo CA, Wakefield SM, Trivedi MH,
Journal of psychiatric research
2023 May
161
179-187
Predictors of response and remission in patients with treatment-resistant depression: A post hoc pooled analysis of two acute trials of esketamine nasal spray.
Turkoz I, Nelson JC, Wilkinson ST, Borentain S, Macaluso M, Trivedi MH, Williamson D, Sheehan JJ, Salvadore G, Singh J, Daly E,
Psychiatry research
2023 May
323
115165
Psychometric evaluation of the 9-item Concise Health Risk Tracking - Self-Report (CHRT-SR
) (a measure of suicidal risk) in adolescent psychiatric outpatients in the Texas Youth Depression and Suicide Research Network (TX-YDSRN).
Nandy K, Rush AJ, Slater H, Mayes TL, Minhajuddin A, Jha M, Blader JC, Brown R, Emslie G, Fuselier MN, Garza C, Gushanas K, Kennard B, Storch EA, Wakefield SM, Trivedi MH,
Journal of affective disorders
2023 May
329
548-556
Leveraging the microbiome to understand clinical heterogeneity in depression: findings from the T-RAD study.
Chin Fatt CR, Asbury S, Jha MK, Minhajuddin A, Sethuram S, Mayes T, Kennedy SH, Foster JA, Trivedi MH,
Translational psychiatry
2023 Apr
13
139
Considering depression as a secondary outcome in the optimization of physical activity interventions for breast cancer survivors in the PACES trial: a factorial randomized controlled trial.
Rethorst CD, Carmody TJ, Argenbright KE, Mayes TL, Hamann HA, Trivedi MH,
The international journal of behavioral nutrition and physical activity
2023 Apr
20
47
Correction: Depression education fotonovela for engagement of Hispanic patients in treatment: a randomized clinical trial.
Sanchez K, Eghaneyan BH, Killian MO, Cabassa LJ, Trivedi MH,
BMC psychiatry
2023 Apr
23
269
Examining a Resilience Mental Health App in Adolescents: Acceptability and Feasibility Study.
Elledge DK, Lee SC, Stewart SM, Pop R, Trivedi MH, Hughes JL,
JMIR formative research
2023 Mar
e38042
Characterizing inflammatory profiles of suicidal behavior in adolescents: Rationale and design.
Chin Fatt C, Ayvaci ER, Jha MK, Emslie G, Gibson S, Minhajuddin AT, Mayes TL, Farrar JD, Trivedi MH,
Journal of affective disorders
2023 Mar
325
55-61
A gender-based secondary analysis of the ADAPT-2 combination naltrexone and bupropion treatment for methamphetamine use disorder trial.
Levander XA, Carmody T, Cook RR, Potter JS, Trivedi MH, Korthuis PT, Shoptaw S,
Addiction (Abingdon, England)
2023 Mar
Temporal multi-step predictive modeling of remission in major depressive disorder using early stage treatment data; STAR*D based machine learning approach.
Salem H, Huynh T, Topolski N, Mwangi B, Trivedi MH, Soares JC, Rush AJ, Selvaraj S,
Journal of affective disorders
2023 Mar
324
286-293
The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder.
Strawn JR, Mills JA, Suresh V, Mayes T, Gentry MT, Trivedi M, Croarkin PE,
Journal of psychiatric research
2023 Mar
159
266-273
Naltrexone plus bupropion reduces cigarette smoking in individuals with methamphetamine use disorder: A secondary analysis from the CTN ADAPT-2 trial.
Schmitz JM, Stotts AL, Yoon JH, Northrup TF, Villarreal YR, Yammine L, Weaver MF, Carmody T, Shoptaw S, Trivedi MH,
Journal of substance use and addiction treatment
2023 Feb
208987
Data driven clusters derived from resting state functional connectivity: Findings from the EMBARC study.
Chin Fatt CR, Minhajuddin A, Jha MK, Mayes T, Rush AJ, Trivedi MH,
Journal of psychiatric research
2023 Feb
158
150-156
AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationale.
Fu CHY, Erus G, Fan Y, Antoniades M, Arnone D, Arnott SR, Chen T, Choi KS, Fatt CC, Frey BN, Frokjaer VG, Ganz M, Garcia J, Godlewska BR, Hassel S, Ho K, McIntosh AM, Qin K, Rotzinger S, Sacchet MD, Savitz J, Shou H, Singh A, Stolicyn A, Strigo I, Strother SC, Tosun D, Victor TA, Wei D, Wise T, Woodham RD, Zahn R, Anderson IM, Deakin JFW, Dunlop BW, Elliott R, Gong Q, Gotlib IH, Harmer CJ, Kennedy SH, Knudsen GM, Mayberg HS, Paulus MP, Qiu J, Trivedi MH, Whalley HC, Yan CG, Young AH, Davatzikos C,
BMC psychiatry
2023 Jan
23
59
Intranasal esketamine effectively treats treatment-resistant depression in adults regardless of baseline irritability.
Jha MK, Williamson DJ, Magharehabed G, Turkoz I, Daly EJ, Trivedi MH,
Journal of affective disorders
2023 Jan
321
153-160
Reward Behavior Disengagement, a Neuroeconomic Model-Based Objective Measure of Reward Pathology in Depression: Findings from the EMBARC Trial
Giles MA, Cooper CM, Jha MK, Chin Fatt CR, Pizzagalli DA, Mayes TL, Webb CA, Greer TL, Etkin A, Trombello JM, Chase HW, Phillips ML, McInnis MG, Carmody T, Adams P, Parsey RV, McGrath PJ, Weissman M, Kurian BT, Fava M, Trivedi MH
Behavioral Sciences
2023
13
Effects of Mental Illness Exposure From Parents and Friends on Adolescent Mental Health and Well-Being
Anderson Jacqueline R, Nandy K, Fuller Anne K, Mayes Taryn L, Spinelli S, Brann S, Padilla F, Hughes Jennifer L, Trivedi Madhukar H.
Psychiatric Annal
2023
53
228-235
The Quick Inventory of Depressive Symptomatology, Adolescent Version (QIDS-A17): A Psychometric Evaluation
Haley CL, Kennard BD , Morris DW, Bernstein IH, Carmody T, Emslie GJ, Mayes TL , Rush AJ
Neuropsychiatric Disease and Treatment
2023
198
1085-1102
The 9-item Concise Health Risk Tracking – Self-Report (CHRT-SR9) measure of suicidal risk: Performance in adult primary care patients
Karabi Nandy, A. Johnm Rush, Thomas J. Carmody, Taryn L. Mayes, Madhukar H. Trivedi
Frontiers in Psychiatry
2023
14
Treatment efficacy and effectiveness in adults with major depressive disorder and childhood trauma history: a systematic review and meta-analysis.
The lancet. Psychiatry
2022 Nov
11
860-873
Immune characterization of suicidal behavior in female adolescents.
Chin Fatt CR, Farrar JD, Jha MK, Minhajuddin A, Mayes T, Foster JA, Trivedi MH,
Brain, behavior, & immunity - health
2022 Nov
25
100499
Effect of Concomitant Benzodiazepines on the Antidepressant Effects of Ketamine: Findings From the RAPID Intravenous Ketamine Study.
Feeney A, Hoeppner BB, Freeman MP, Flynn M, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, DeBattista C, Ionescu DF, Cusin C, Papakostas GI, Jha MK, Fava M,
The Journal of clinical psychiatry
2022 Nov
84
The Concise Health Risk Tracking - Self-Report (CHRT-SR)-A measure of suicidal risk: Performance in adolescent outpatients.
Nandy K, Rush AJ, Carmody TJ, Kulikova A, Mayes TL, Emslie G, Trivedi MH,
International journal of methods in psychiatric research
2022 Oct
e1944
Accelerated Brain Aging in Adults with Major Depressive Disorder Predicts Poorer Outcome with Sertraline: Findings from the EMBARC Study.
Jha MK, Fatt CC, Minhajuddin A, Mayes T, Trivedi MH,
Biological psychiatry. Cognitive neuroscience and neuroimaging
2022 Sep
BLENDS: Augmentation of Functional Magnetic Resonance Images for Machine Learning using Anatomically Constrained Warping.
Nguyen KP, Raval V, Minhajuddin A, Carmody T, Trivedi MH, Dewey RB, Montillo AA,
Brain connectivity
2022 Sep
Accelerated brain aging in individuals with diabetes: Association with poor glycemic control and increased all-cause mortality.
Jha MK, Chin Fatt CR, Minhajuddin A, Mayes TL, Berry JD, Trivedi MH,
Psychoneuroendocrinology
2022 Sep
145
105921
A Characterization of the Clinical Global Impression Scale Thresholds in the Treatment of Adolescent Depression Across Multiple Rating Scales.
Zhang CY, Voort JLV, Yuruk D, Mills JA, Emslie GJ, Kennard BD, Mayes T, Trivedi M, Bobo WV, Strawn JR, Athreya AP, Croarkin PE,
Journal of child and adolescent psychopharmacology
2022 Jun
32
278-287
Montgomery-Asberg Depression Rating Scale factors in treatment-resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine.
Borentain S, Gogate J, Williamson D, Carmody T, Trivedi M, Jamieson C, Cabrera P, Popova V, Wajs E, DiBernardo A, Daly EJ,
International journal of methods in psychiatric research
2022 Jun
e1927
Toward a Definition of "No Meaningful Benefit" From Antidepressant Treatment: An Equipercentile Analysis With Cross-Trial Validation Across Multiple Rating Scales.
Zhang C, Virani S, Mayes T, Carmody T, Croarkin PE, Weinshilboum R, Rush AJ, Trivedi M, Athreya AP, Bobo WV,
The Journal of clinical psychiatry
2022 Jun
83
Alterations in resting-state functional activity and connectivity for major depressive disorder appetite and weight disturbance phenotypes.
Piccolo M, Belleau EL, Holsen LM, Trivedi MH, Parsey RV, McGrath PJ, Weissman MM, Pizzagalli DA, Javaras KN,
Psychological medicine
2022 Jun
1-11
Youth Aware of Mental Health (YAM) Program With Texas Adolescents: Depression, Anxiety, and Substance Use Outcomes.
Trivedi MH, Nandy K, Mayes TL, Wang T, Forbes K, Anderson JR, Fuller A, Hughes JL,
The Journal of clinical psychiatry
2022 May
83
Dynamic Resting-State Network Biomarkers of Antidepressant Treatment Response.
Kaiser RH, Chase HW, Phillips ML, Deckersbach T, Parsey RV, Fava M, McGrath PJ, Weissman M, Oquendo MA, McInnis MG, Carmody T, Cooper CM, Trivedi MH, Pizzagalli DA,
Biological psychiatry
2022 Apr
Experiencing bullying's impact on adolescent depression and anxiety: Mediating role of adolescent resilience.
Anderson JR, Mayes TL, Fuller A, Hughes JL, Minhajuddin A, Trivedi M,
Journal of affective disorders
2022 Apr
Pitfalls and Recommended Strategies and Metrics for Suppressing Motion Artifacts in Functional MRI.
Raval V, Nguyen KP, Pinho M, Dewey RB, Trivedi M, Montillo AA,
Neuroinformatics
2022 Mar
Neural substrates of emotional conflict with anxiety in major depressive disorder: Findings from the Establishing Moderators and biosignatures of Antidepressant Response in Clinical Care (EMBARC) randomized controlled trial.
Trombello JM, Cooper CM, Fatt CC, Grannemann BD, Carmody TJ, Jha MK, Mayes TL, Greer TL, Yezhuvath U, Aslan S, Pizzagalli DA, Weissman MM, Webb CA, Dillon DG, McGrath PJ, Fava M, Parsey RV, McInnis MG, Etkin A, Trivedi MH,
Journal of psychiatric research
2022 Mar
149
243-251
Multi-Omics Characterization of Early- and Adult-Onset Major Depressive Disorder.
Grant CW, Barreto EF, Kumar R, Kaddurah-Daouk R, Skime M, Mayes T, Carmody T, Biernacka J, Wang L, Weinshilboum R, Trivedi MH, Bobo WV, Croarkin PE, Athreya AP,
Journal of personalized medicine
2022 Mar
12
Evidence for machine learning guided early prediction of acute outcomes in the treatment of depressed children and adolescents with antidepressants.
Athreya AP, Vande Voort JL, Shekunov J, Rackley SJ, Leffler JM, McKean AJ, Romanowicz M, Kennard BD, Emslie GJ, Mayes T, Trivedi M, Wang L, Weinshilboum RM, Bobo WV, Croarkin PE,
Journal of child psychology and psychiatry, and allied disciplines
2022 Mar
Time for united action on depression: a Lancet-World Psychiatric Association Commission.
Herrman H, Patel V, Kieling C, Berk M, Buchweitz C, Cuijpers P, Furukawa TA, Kessler RC, Kohrt BA, Maj M, McGorry P, Reynolds CF, Weissman MM, Chibanda D, Dowrick C, Howard LM, Hoven CW, Knapp M, Mayberg HS, Penninx BWJH, Xiao S, Trivedi M, Uher R, Vijayakumar L, Wolpert M,
Lancet (London, England)
2022 03
399
10328
957-1022
Socioeconomic Predictors of Treatment Outcomes Among Adults With Major Depressive Disorder.
Mills JA, Suresh V, Chang L, Mayes T, Croarkin PE, Trivedi MH, Strawn JR,
Psychiatric services (Washington, D.C.)
2022 Mar
appips202100559
Moderation of buprenorphine therapy for cocaine dependence efficacy by variation of the Prodynorphin gene.
Nielsen DA, Walker R, Graham DP, Nielsen EM, Hamon SC, Hillhouse M, Shmueli-Blumberg D, Lawson WB, Shores-Wilson K, Settles-Reaves BD, Rotrosen J, Trivedi MH, Saxon AJ, Ling W, Kosten TR,
European journal of clinical pharmacology
2022 Feb
Circulating microRNA associated with future relapse status in major depressive disorder.
Li QS, Galbraith D, Morrison RL, Trivedi MH, Drevets WC,
Frontiers in psychiatry
2022
13
937360
Network science approach elucidates integrative genomic-metabolomic signature of antidepressant response and lifetime history of attempted suicide in adults with major depressive disorder.
Grant CW, Wilton AR, Kaddurah-Daouk R, Skime M, Biernacka J, Mayes T, Carmody T, Wang L, Lazaridis K, Weinshilboum R, Bobo WV, Trivedi MH, Croarkin PE, Athreya AP,
Frontiers in pharmacology
2022
13
984383
Psychometric and Clinical Evaluation of the Clinician (VQIDS-C
) and Self-Report (VQIDS-SR
) Versions of the Very Quick Inventory of Depressive Symptoms.
Rush AJ, Madia ND, Carmody T, Trivedi MH,
Neuropsychiatric disease and treatment
2022
18
289-302
Accelerated Brain Aging in Major Depressive Disorder Predicts Poorer Treatment Outcomes with Sertraline: Findings From the EMBARC Study
Chin Fatt C, Jha M, Minhajuddin A, Mayes T, Trivedi M
Biological Psychiatry
2022
91
S4
Accelerated Brain Aging is Independently Associated With Increased Likelihood of All-Cause Mortality: Findings From the Second Wave of Dallas Heart Study (DHS-2)
M. Jha, A. Minhajuddin, C. C. Fatt, T. Mayes, J. Berry and M. Trivedi
Biological Psychiatry
2022
91
Fibroblast growth factor 21 (FGF21) is increased in MDD and interacts with body mass index (BMI) to affect depression trajectory.
Mason BL, Minhajuddin A, Czysz AH, Jha MK, Gadad BS, Mayes TL, Trivedi MH,
Translational psychiatry
2022 01
12
16
Gut Dysbiosis and Accelerated Brain Aging: Findings From the Texas Resilience Against Depression (T-RAD) Study
C. Chin Fatt, M. Jha, S. Asbury, A. Minhajuddin, J. Foster and M. Trivedi
Biological Psychiatry
2022
91
S4
Depression education fotonovela for engagement of Hispanic patients in treatment: a randomized clinical trial.
Sanchez K, Eghaneyan BH, Killian MO, Cabassa LJ, Trivedi MH,
BMC psychiatry
2021 Dec
21
635
Comparison of inflammatory markers as moderators of depression outcomes: A CO-MED study.
Czysz AH, Mason BL, Li Q, Chin-Fatt C, Minhajuddin A, Carmody T, Trivedi MH,
Journal of affective disorders
2021 12
295
1066-1071
Corrigendum to 'Two Trajectories of Depressive Symptom Reduction Throughout Behavioral Activation Teletherapy Among Underserved, Ethnically Diverse, Primary Care Patients: A VitalSign
Report'. [Behav. Therapy 51 (2020) 958-971].
Trombello JM, South C, Sánchez A, Kahalnik F, Kennard BD, Trivedi MH,
Behavior therapy
2021 Nov
52
1558
Psychometric properties of the Generalized Anxiety Disorder 7-item scale in youth: Screening in a primary care sample.
Hughes JL, Grannemann BD, Trombello JM, Martin WB, Fuller AK, Trivedi MH,
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists
2021 Nov
33
241-250
A primary care first (PCP-first) model to screen and treat depression: A VitalSign
report from a second cohort of 32,106 patients.
Wang MZ, Jha MK, Minhajuddin A, Pipes R, Levinson S, Mayes TL, Greer TL, Trivedi MH,
General hospital psychiatry
2021 Nov
74
1-8
Multi-omics driven predictions of response to acute phase combination antidepressant therapy: a machine learning approach with cross-trial replication.
Joyce JB, Grant CW, Liu D, MahmoudianDehkordi S, Kaddurah-Daouk R, Skime M, Biernacka J, Frye MA, Mayes T, Carmody T, Croarkin PE, Wang L, Weinshilboum R, Bobo WV, Trivedi MH, Athreya AP,
Translational psychiatry
2021 10
11
513
The effectiveness of enhanced evidence-based care for depressive disorders: a meta-analysis of randomized controlled trials.
Xiao L, Qi H, Zheng W, Xiang YT, Carmody TJ, Mayes TL, Trivedi MH, Wang G,
Translational psychiatry
2021 10
11
531
Dysregulation of mitochondrial dynamics, mitophagy and apoptosis in major depressive disorder: Does inflammation play a role?
Scaini G, Mason BL, Diaz AP, Jha MK, Soares JC, Trivedi MH, Quevedo J,
Molecular psychiatry
2021 Oct
Irritability as an independent predictor of concurrent and future suicidal ideation in adults with stimulant use disorder: Findings from the STRIDE study.
Jha MK, Minhajuddin A, Chin Fatt C, Shoptaw S, Kircanski K, Stringaris A, Leibenluft E, Trivedi M,
Journal of affective disorders
2021 09
292
108-113
Patterns of Pretreatment Reward Task Brain Activation Predict Individual Antidepressant Response: Key Results From the EMBARC Randomized Clinical Trial.
Nguyen KP, Chin Fatt C, Treacher A, Mellema C, Cooper C, Jha MK, Kurian B, Fava M, McGrath PJ, Weissman M, Phillips ML, Trivedi MH, Montillo AA,
Biological psychiatry
2021 Sep
Identifying novel mechanisms and treatment targets for irritability and aggression in psychiatric disorders.
Jha MK, Trivedi MH,
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
2021 Sep
Dysfunction of default mode network is associated with active suicidal ideation in youths and young adults with depression: Findings from the T-RAD study.
Chin Fatt CR, Jha MK, Minhajuddin A, Mayes T, Ballard ED, Trivedi MH,
Journal of psychiatric research
2021 Aug
142
258-262
Impact of the COVID-19 pandemic on adults with current and prior depression: initial findings from the longitudinal Texas RAD study.
Czysz AH, Nandy K, Hughes JL, Minhajuddin A, Chin Fatt CR, Trivedi MH,
Journal of affective disorders
2021 Jul
294
103-108
The effect of esketamine in patients with treatment-resistant depression with and without comorbid anxiety symptoms or disorder.
Daly EJ, Turkoz I, Salvadore G, Fedgchin M, Ionescu DF, Starr HL, Borentain S, Trivedi MH, Thase ME, Singh JB,
Depression and anxiety
2021 Jul
Prediction of short-term antidepressant response using probabilistic graphical models with replication across multiple drugs and treatment settings.
Athreya AP, Brückl T, Binder EB, John Rush A, Biernacka J, Frye MA, Neavin D, Skime M, Monrad D, Iyer RK, Mayes T, Trivedi M, Carter RE, Wang L, Weinshilboum RM, Croarkin PE, Bobo WV,
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
2021 06
46
1272-1282
The effect of single administration of intravenous ketamine augmentation on suicidal ideation in treatment-resistant unipolar depression: Results from a randomized double-blind study.
Feeney A, Hock RS, Freeman MP, Flynn M, Hoeppner B, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, Debattista C, Ionescu DF, Fava M, Papakostas GI,
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
2021 Jun
49
122-132
Smoking status links habenular volume to glycated hemoglobin: Findings from the Human Connectome Project-Young Adult.
Jha MK, Kim JW, Kenny PJ, Chin Fatt C, Minhajuddin A, Salas R, Ely BA, Klein M, Abdallah CG, Xu J, Trivedi MH,
Psychoneuroendocrinology
2021 Jun
131
105321
Impact of childhood maltreatment on outcomes of antidepressant medication in chronic and/or recurrent depression.
Medeiros GC, Prueitt WL, Rush AJ, Minhajuddin A, Czysz AH, Patel SS, Trombello J, Trivedi MH,
Journal of affective disorders
2021 May
291
39-45
Suicidal Ideation and Depression Among Adolescent and Young Adult Cancer Patients.
Giberson SA, Hall BC, Jester B, Short VM, Roaten K, de la Garza N, Trivedi MH, Howe-Martin L,
Journal of adolescent and young adult oncology
2021 Apr
Cross-Sectional Associations Among Symptoms of Pain, Irritability, and Depression and How These Symptoms Relate to Social Functioning and Quality of Life: Findings From the EMBARC and STRIDE Studies and the VitalSign6 Project.
Jha MK, Schatzberg A, Minhajuddin A, Chin Fatt C, Mayes TL, Trivedi MH,
The Journal of clinical psychiatry
2021 Apr
82
Electronic Mental Health Screening in a Pediatric Heart Failure and Transplant Clinic.
Anton CM, Drake MB, Butts RJ, Cao T, Rezaeizadeh A, Trivedi MH, Triplett KN,
Journal of clinical psychology in medical settings
2021 Mar
Psychometric Evaluation of the Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire in a General Youth Population.
Anderson JR, Killian M, Fuller A, Hughes JL, Byerly M, Lindow J, John Rush A, Trivedi MH,
Child psychiatry and human development
2021 Mar
Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care.
Dela Cruz AM, Walker R, Pipes R, Wakhlu S, Trivedi MH,
Addiction science & clinical practice
2021 Feb
16
12
Preliminary Evidence for Sociotropy and Autonomy in Relation to Antidepressant Treatment Outcome.
Cardinale R, Menkes MW, Andrews CM, Webb CA, Jha MK, Trombello JM, Trivedi MH, McInnis MG, Deldin PJ,
The Psychiatric quarterly
2021 Feb
Functional Neuroimaging Moderators of Improvement in Irritability With Antidepressants vs. Placebo in Adults With Major Depressive Disorder: Findings From the EMBARC Study
Jha, Manish Fatt, Cherise Minhajuddin, Abu Kircanski, Katharina Leibenluft, Ellen Trivedi, Madhukar
Biological Psychiatry
2021
89
S47
Bupropion and Naltrexone in Methamphetamine Use Disorder.
Trivedi MH, Walker R, Ling W, Dela Cruz A, Sharma G, Carmody T, Ghitza UE, Wahle A, Kim M, Shores-Wilson K, Sparenborg S, Coffin P, Schmitz J, Wiest K, Bart G, Sonne SC, Wakhlu S, Rush AJ, Nunes EV, Shoptaw S,
The New England journal of medicine
2021 01
384
140-153
Moderators of treatment response to exercise in participants with stimulant use disorder: Exploratory results from the Stimulant Reduction using Dosed Exercise (STRIDE)CTN-0037 study
Rethorst C, Henley S, Carmody T, dela Cruz A, Greer T, Walker R, Stoutenberg M, Trivedi M
Mental Health and Physical Activity
2021
21
School Personnel and Parents? Concerns Related to COVID-19 Pandemic?s Impact Related to Schools
Anderson JR, Hughes JL, Trivedi MH
School Psychology Review
2021
50
519-529
Association Between Habenular Volume and Hemoglobin A1c in Young Adults Differs on the Basis of Smoking Status: Findings From the Human Connectome Project
Jha M, Kim J, Kenny P, Chin Fatt C, Minhajuddin M,Salas R, Klein M, Ely B, Abdallah C, Xu J, Trivedi M
Biological Psychiatry
2021
89
S271-S272
Clinically Significant Changes in the 17- and 6-Item Hamilton Rating Scales for Depression: A STAR*D Report.
Rush AJ, South C, Jain S, Agha R, Zhang M, Shrestha S, Khan Z, Hassan M, Trivedi MH,
Neuropsychiatric disease and treatment
2021
17
2333-2345
Brain Ventricle Morphology as Predictor of Treatment-Response- Findings From the EMBARC-Study
Murck H, Fava M, Cusin C, Chin Fatt C, Trivedi M
Biological Psychiatry
2021
89
S367-S368
Functional Neuroimaging Moderators of Improvement in Irritability With Antidepressants vs. Placebo in Adults With Major Depressive Disorder: Findings From the EMBARC Study
Jha M, Chin Fatt C, Minhajuddin A, Kircanski K, Leibenluft E, Trivedi M
Biological Psychiatry
2021
89
S47
Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Center for Clinical Trials Network Task Force report.
Joudrey PJ, Bart G, Brooner RK, Brown L, Dickson-Gomez J, Gordon A, Kawasaki SS, Liebschutz JM, Nunes E, McCarty D, Schwartz RP, Szapocnik J, Trivedi M, Tsui JI, Williams A, Wu LT, Fiellin DA,
Substance abuse
2021
42
245-254
Neurocircuit Mechanisms of Active Suicidal Ideation in Youths and Young Adults: Findings From the T-Rad Study
Chin Fatt C, Jha M, Minhajuddin A, Mayes T, Trivedi M
Biological Psychiatry
2021
89
S82
2020 Articles of Import and Impact.
Kalin NH, Binder E, Brady KT, Lewis DA, Pine DS, Rodriguez C, Trivedi MH, Edwards ML,
The American journal of psychiatry
2021 01
178
13-16
Effect of Adjunctive Pimavanserin on Sleep/Wakefulness in Patients With Major Depressive Disorder: Secondary Analysis From CLARITY.
Jha MK, Fava M, Freeman MP, Thase ME, Papakostas GI, Shelton RC, Trivedi MH, Dirks B, Liu K, Stankovic S,
The Journal of clinical psychiatry
2020 Dec
82
A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
Dodd S, Bauer M, Carvalho AF, Eyre H, Fava M, Kasper S, Kennedy SH, Khoo JP, Lopez Jaramillo C, Malhi GS, McIntyre RS, Mitchell PB, Castro AMP, Ratheesh A, Severus E, Suppes T, Trivedi MH, Thase ME, Yatham LN, Young AH, Berk M,
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
2020 Dec
1-20
Differential response to SSRI versus Placebo and distinct neural signatures among data-driven subgroups of patients with major depressive disorder.
Chin Fatt CR, Cooper CM, Jha MK, Minhajuddin A, Rush AJ, Trombello JM, Fava M, McInnis M, Weissman M, Trivedi MH,
Journal of affective disorders
2020 Dec
282
602-610
Reply to: EEG-based model and antidepressant response.
Wu W, Pizzagall DA, Trivedi MH, Etkin A,
Nature biotechnology
2020 Dec
Clinically Meaningful Changes on Depressive Symptom Measures and Patient-Reported Outcomes in Patients with Treatment-Resistant Depression.
Turkoz I, Alphs L, Singh J, Jamieson C, Daly E, Shawi M, Sheehan JJ, Trivedi MH, Rush AJ,
Acta psychiatrica Scandinavica
2020 Nov
Sex-specific differences in the association between body mass index and brain aging in young adults: Findings from the human connectome project.
Chin Fatt CR, Jha MK, Minhajuddin A, Mayes T, Trivedi MH,
Psychoneuroendocrinology
2020 Nov
124
105059
Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial.
Ang YS, Bruder GE, Keilp JG, Rutherford A, Alschuler DM, Pechtel P, Webb CA, Carmody T, Fava M, Cusin C, McGrath PJ, Weissman M, Parsey R, Oquendo MA, McInnis MG, Cooper CM, Deldin P, Trivedi MH, Pizzagalli DA,
Psychological medicine
2020 Nov
1-9
Addressing adherence to antidepressant treatment for depression.
Mayes TL, Trivedi MH,
Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)
2020 Oct
Identification of psychiatric disorder subtypes from functional connectivity patterns in resting-state electroencephalography.
Zhang Y, Wu W, Toll RT, Naparstek S, Maron-Katz A, Watts M, Gordon J, Jeong J, Astolfi L, Shpigel E, Longwell P, Sarhadi K, El-Said D, Li Y, Cooper C, Chin-Fatt C, Arns M, Goodkind MS, Trivedi MH, Marmar CR, Etkin A,
Nature biomedical engineering
2020 Oct
Profiles of depression in a treatment-seeking Hispanic population: Psychometric properties of the Patient Health Questionnaire-9.
Killian MO, Sanchez K, Eghaneyan BH, Cabassa LJ, Trivedi MH,
International journal of methods in psychiatric research
2020 Aug
e1851
Dissecting the impact of depression on decision-making.
Lawlor VM, Webb CA, Wiecki TV, Frank MJ, Trivedi M, Pizzagalli DA, Dillon DG,
Psychological medicine
2020 07
50
10
1613-1622
Dorsolateral Prefrontal Cortex and Subcallosal Cingulate Connectivity Show Preferential Antidepressant Response in Major Depressive Disorder.
Chin Fatt CR, Cooper C, Jha MK, Aslan S, Grannemann B, Kurian B, Greer TL, Fava M, Weissman M, McGrath PJ, Parsey RV, Etkin A, Phillips ML, Trivedi MH,
Biological psychiatry. Cognitive neuroscience and neuroimaging
2020 Jul
Harmonized Outcome Measures for Use in Depression Patient Registries and Clinical Practice.
Gliklich RE, Leavy MB, Cosgrove L, Simon GE, Gaynes BN, Peterson LE, Olin B, Cole C, DePaulo JR, Wang P, Crowe CM, Cusin C, Nix M, Berliner E, Trivedi MH,
Annals of internal medicine
2020 May
Recognizing Inadequate Response in Patients With Major Depressive Disorder.
Jackson WC, Papakostas GI, Rafeyan R, Trivedi MH,
The Journal of clinical psychiatry
2020 May
Improvement of sexual functioning during treatment of MDD with adjunctive pimavanserin: A secondary analysis.
Freeman MP, Fava M, Dirks B, Jha MK, Papakostas GI, Shelton RC, Thase ME, Trivedi MH, Liu K, Stankovic S,
Depression and anxiety
2020 Apr
Anger attacks are associated with persistently elevated irritability in MDD: findings from the EMBARC study.
Jha MK, Fava M, Minhajuddin A, Chin Fatt C, Mischoulon D, Wakhlu N, Trombello JM, Cusin C, Trivedi MH,
Psychological medicine
2020 Mar
1-9
Identifying and responding to trial implementation challenges during multisite clinical trials.
Greer TL, Walker R, Rethorst CD, Northrup TF, Warden D, Horigian VE, Silverstein M, Shores-Wilson K, Stotts AL, Trivedi MH,
Journal of substance abuse treatment
2020 Mar
112S
63-72
Anatomically-Informed Data Augmentation for Functional MRI with Applications to Deep Learning.
Nguyen KP, Fatt CC, Treacher A, Mellema C, Trivedi MH, Montillo A,
Proceedings of SPIE--the International Society for Optical Engineering
2020 Feb
11313
The Adolescent Resilience Questionnaire: Validation of a Shortened Version in U.S. Youths.
Anderson JR, Killian M, Hughes JL, Rush AJ, Trivedi MH,
Frontiers in psychology
2020
11
606373
Inflammation and Response to Sertraline Treatment in Patients With CKD and Major Depression.
Gregg LP, Carmody T, Le D, Toto RD, Trivedi MH, Hedayati SS,
American journal of kidney diseases : the official journal of the National Kidney Foundation
2019 Dec
Higher S100B Levels Predict Persistently Elevated Anhedonia with Escitalopram Monotherapy Versus Antidepressant Combinations: Findings from CO-MED Trial.
Jha MK, Minhajuddin A, Gadad BS, Chin Fatt C, Trivedi MH,
Pharmaceuticals (Basel, Switzerland)
2019 Dec
12
Predicting Response to the Antidepressant Bupropion using Pretreatment fMRI.
Nguyen KP, Fatt CC, Treacher A, Mellema C, Trivedi MH, Montillo A,
Predictive intelligence in medicine : second International Workshop, PRIME 2019, held in Conjunction with MICCAI 2019, Shenzhen, China, October 13, 2019, Proceedings. PRIME (Workshop) (2nd : 2019 : Shenzhen Shi, China)
2019 Oct
11843
53-62
Culturally adapted depression education and engagement in treatment among Hispanics in primary care: outcomes from a pilot feasibility study.
Sanchez K, Killian MO, Eghaneyan BH, Cabassa LJ, Trivedi MH,
BMC family practice
2019 Oct
20
140
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).
Fedgchin M, Trivedi M, Daly EJ, Melkote R, Lane R, Lim P, Vitagliano D, Blier P, Fava M, Liebowitz M, Ravindran A, Gaillard R, Ameele HVD, Preskorn S, Manji H, Hough D, Drevets WC, Singh JB,
The international journal of neuropsychopharmacology
2019 10
22
10
616-630
Dysfunctional adaptive immune response in adolescents and young adults with suicide behavior.
Jha MK, Cai L, Minhajuddin A, Fatt CC, Furman JL, Gadad BS, Mason BL, Greer TL, Hughes JL, Xiao G, Emslie G, Kennard B, Mayes T, Trivedi MH,
Psychoneuroendocrinology
2019 Oct
111
104487
Examining raphe-amygdala structural connectivity as a biological predictor of SSRI response.
Pillai RLI, Huang C, LaBella A, Zhang M, Yang J, Trivedi M, Weissman M, McGrath P, Fava M, Kurian B, Cooper C, McInnis M, Oquendo MA, Pizzagalli DA, Parsey RV, DeLorenzo C,
Journal of affective disorders
2019 Sep
256
8-16
Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major Depression.
Chin Fatt CR, Jha MK, Cooper CM, Fonzo G, South C, Grannemann B, Carmody T, Greer TL, Kurian B, Fava M, McGrath PJ, Adams P, McInnis M, Parsey RV, Weissman M, Phillips ML, Etkin A, Trivedi MH,
The American journal of psychiatry
2019 Sep
appiajp201918070870
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Adjunctive Pimavanserin in Patients With Major Depressive Disorder and an Inadequate Response to Therapy (CLARITY).
Fava M, Dirks B, Freeman MP, Papakostas GI, Shelton RC, Thase ME, Trivedi MH, Liu K, Stankovic S,
The Journal of clinical psychiatry
2019 Sep
80
Discovery and replication of cerebral blood flow differences in major depressive disorder.
Cooper CM, Chin Fatt CR, Liu P, Grannemann BD, Carmody T, Almeida JRC, Deckersbach T, Fava M, Kurian BT, Malchow AL, McGrath PJ, McInnis M, Oquendo MA, Parsey RV, Bartlett E, Weissman M, Phillips ML, Lu H, Trivedi MH,
Molecular psychiatry
2019 Aug
Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis.
Liu JJ, Wei YB, Strawbridge R, Bao Y, Chang S, Shi L, Que J, Gadad BS, Trivedi MH, Kelsoe JR, Lu L,
Molecular psychiatry
2019 Aug
Symptoms of Major Depressive Disorder Scale: Performance of a Novel Patient-Reported Symptom Measure.
Bushnell DM, McCarrier KP, Bush EN, Abraham L, Jamieson C, McDougall F, Trivedi MH, Thase ME, Carpenter L, Coons SJ,
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
2019 Aug
22
906-915
A Structured Approach to Detecting and Treating Depression in Primary Care: VitalSign6 Project.
Jha MK, Grannemann BD, Trombello JM, Clark EW, Eidelman SL, Lawson T, Greer TL, Rush AJ, Trivedi MH,
Annals of family medicine
2019 Jul
17
326-335
Exploring the Association of Sex Differences and Exposure to Maternal Smoking With Low Fetal Growth.
Jha MK, Minhajuddin A, Trivedi M,
JAMA psychiatry
2019 07
76
766-767
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.
Popova V, Daly EJ, Trivedi M, Cooper K, Lane R, Lim P, Mazzucco C, Hough D, Thase ME, Shelton RC, Molero P, Vieta E, Bajbouj M, Manji H, Drevets WC, Singh JB,
The American journal of psychiatry
2019 06
176
428-438
Fatigue in Nondialysis Chronic Kidney Disease: Correlates and Association with Kidney Outcomes.
Gregg LP, Jain N, Carmody T, Minhajuddin AT, Rush AJ, Trivedi MH, Hedayati SS,
American journal of nephrology
2019 Jun
1-11
When Discontinuing SSRI Antidepressants Is a Challenge: A Response to Letters to the Editor.
Jha MK, Trivedi MH,
The American journal of psychiatry
2019 Jun
176
488-489
Sex differences in the association of baseline c-reactive protein (CRP) and acute-phase treatment outcomes in major depressive disorder: Findings from the EMBARC study.
Jha MK, Minhajuddin A, Chin-Fatt C, Greer TL, Carmody TJ, Trivedi MH,
Journal of psychiatric research
2019 Jun
113
165-171
Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder.
Thase ME, Stanford AD, Memisoglu A, Martin W, Claxton A, Alexander Bodkin J, Trivedi MH, Fava M, Yu M, Pathak S,
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
2019 Jun
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
Daly EJ, Trivedi MH, Janik A, Li H, Zhang Y, Li X, Lane R, Lim P, Duca AR, Hough D, Thase ME, Zajecka J, Winokur A, Divacka I, Fagiolini A, Cubala WJ, Bitter I, Blier P, Shelton RC, Molero P, Manji H, Drevets WC, Singh JB,
JAMA psychiatry
2019 Jun
VitalSign
: A Primary Care First (PCP-First) Model for Universal Screening and Measurement-Based Care for Depression.
Trivedi MH, Jha MK, Kahalnik F, Pipes R, Levinson S, Lawson T, Rush AJ, Trombello JM, Grannemann B, Tovian C, Kinney R, Clark EW, Greer TL,
Pharmaceuticals (Basel, Switzerland)
2019 May
12
Acute and long-term cannabis use among stimulant users: Results from CTN-0037 Stimulant Reduction Intervention using Dosed Exercise (STRIDE) Randomized Control Trial.
Vidot DC, Rethorst CD, Carmody TJ, Stoutenberg M, Walker R, Greer TL, Trivedi MH,
Drug and alcohol dependence
2019 May
200
139-144
Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity.
Jha MK, Minhajuddin A, South C, Rush AJ, Trivedi MH,
The American journal of psychiatry
2019 May
176
358-366
Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED Trials.
Jha MK, South C, Trivedi J, Minhajuddin A, Rush AJ, Trivedi MH,
The international journal of neuropsychopharmacology
2019 Apr
Sensitivity of derived clinical biomarkers to rs-fMRI preprocessing software versions.
Nguyen KP, Fatt CC, Mellema C, Trivedi MH, Montillo A,
Proceedings. IEEE International Symposium on Biomedical Imaging
2019 Apr
2019
1581-1584
VitalSign
: Screening, Diagnosis, and Treatment of Depression for Adolescents Presenting to Pediatric Primary and Specialty Care Settings.
Pop R, Kinney R, Grannemann B, Emslie G, Trivedi MH,
Journal of the American Academy of Child and Adolescent Psychiatry
2019 Apr
Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC Trial.
Cooper CM, Chin Fatt CR, Jha M, Fonzo GA, Grannemann BD, Carmody T, Ali A, Aslan S, Almeida JRC, Deckersbach T, Fava M, Kurian BT, McGrath PJ, McInnis M, Parsey RV, Weissman M, Phillips ML, Lu H, Etkin A, Trivedi MH,
EClinicalMedicine
2019 Apr
10
32-41
Childhood trauma history is linked to abnormal brain connectivity in major depression.
Yu M, Linn KA, Shinohara RT, Oathes DJ, Cook PA, Duprat R, Moore TM, Oquendo MA, Phillips ML, McInnis M, Fava M, Trivedi MH, McGrath P, Parsey R, Weissman MM, Sheline YI,
Proceedings of the National Academy of Sciences of the United States of America
2019 Apr
116
17
8582-8590
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression.
Salloum NC, Fava M, Freeman MP, Flynn M, Hoeppner B, Hock RS, Cusin C, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, Debattista C, Ionescu DF, Papakostas GI
Depression and anxiety
2019 Mar
36
235-243
Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depression.
Freeman MP, Papakostas GI, Hoeppner B, Mazzone E, Judge H, Cusin C, Mathew S, Sanacora G, Iosifescu D, DeBattista C, Trivedi MH, Fava M
Journal of psychiatric research
2019 Mar
110
166-171
The Concise Health Risk Tracking-Self Report: Psychometrics within a placebo-controlled antidepressant trial among depressed outpatients.
Trombello JM, Killian MO, Grannemann BD, Rush AJ, Mayes TL, Parsey RV, McInnis M, Jha MK, Ali A, McGrath PJ, Adams P, Oquendo MA, Weissman MM, Carmody TJ, Trivedi MH
Journal of psychopharmacology (Oxford, England)
2019 Feb
33
185-193
Comparative Efficacy of Therapies for Treatment of Depression for Patients Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial.
Mehrotra R, Cukor D, Unruh M, Rue T, Heagerty P, Cohen SD, Dember LM, Diaz-Linhart Y, Dubovsky A, Greene T, Grote N, Kutner N, Trivedi MH, Quinn DK, Ver Halen N, Weisbord SD, Young BA, Kimmel PL, Hedayati SS
Annals of internal medicine
2019 Feb
Anxiety and anhedonia in depression: Associations with neuroticism and cognitive control.
Liao A, Walker R, Carmody TJ, Cooper C, Shaw MA, Grannemann BD, Adams P, Bruder GE, McInnis MG, Webb CA, Dillon DG, Pizzagalli DA, Phillips ML, Kurian BT, Fava M, Parsey RV, McGrath PJ, Weissman MM, Trivedi MH
Journal of affective disorders
2019 02
245
1070-1078
Toward a very brief quality of life enjoyment and Satisfaction Questionnaire.
Rush AJ, South CC, Jha MK, Grannemann BD, Trivedi MH
Journal of affective disorders
2019 Jan
242
87-95
E-Behavioral Activation in Primary Care for Depression
J. M. TROMBELLO and M. H. TRIVEDI
Evidence-Based Practice in Action: Bridging Clinical Science and Intervention
2019
303
The Stimulant Selective Severity Assessment: A replication and exploratory extension of the Cocaine Selective Severity Assessment
R. Walker, T. F. Northrup, J. Tillitski, I. Bernstein, T. L. Greer and M. H. Trivedi
Substance Use & Misuse
2019
54
351-361
Can targeted metabolomics predict depression recovery? Results from the CO-MED trial.
Czysz AH, South C, Gadad BS, Arning E, Soyombo A, Bottiglieri T, Trivedi MH
Translational psychiatry
2019 Jan
11
Brain regulation of emotional conflict predicts antidepressant treatment response for depression
Fonzo, Gregory A. Etkin, Amit Zhang, Yu Wu, Wei Cooper, Crystal Chin-Fatt, Cherise Jha, Manish K. Trombello, Joseph Deckersbach, Thilo Adams, Phil McInnis, Melvin McGrath, Patrick J. Weissman, Myrna M. Fava, Maurizio Trivedi, Madhukar H.
Nature Human Behaviour
2019
12
1319-1331
Pretreatment Rostral Anterior Cingulate Cortex Connectivity With Salience Network Predicts Depression Recovery: Findings From the EMBARC Randomized Clinical Trial.
Whitton AE, Webb CA, Dillon DG, Kayser J, Rutherford A, Goer F, Fava M, McGrath P, Weissman M, Parsey R, Adams P, Trombello JM, Cooper C, Deldin P, Oquendo MA, McInnis MG, Carmody T, Bruder G, Trivedi MH, Pizzagalli DA
Biological psychiatry
2018 Dec
When Discontinuing SSRI Antidepressants Is a Challenge: Management Tips.
Jha MK, Rush AJ, Trivedi MH
The American journal of psychiatry
2018 Dec
175
12
1176-1184
The Concise Health Risk Tracking Self-Report (CHRT-SR) assessment of suicidality in depressed outpatients: A psychometric evaluation.
De La Garza N, Rush AJ, Killian MO, Grannemann BD, Carmody TJ, Trivedi MH
Depression and anxiety
2018 Oct
Pharmacogenomics and Biomarkers of Depression.
Jha MK, Trivedi MH
Handbook of experimental pharmacology
2018 Oct
Resting EEG Measures of Brain Arousal in a Multisite Study of Major Depression.
Ulke C, Tenke CE, Kayser J, Sander C, Böttger D, Wong LYX, Alvarenga JE, Fava M, McGrath PJ, Deldin PJ, Mcinnis MG, Trivedi MH, Weissman MM, Pizzagalli DA, Hegerl U, Bruder GE
Clinical EEG and neuroscience
2018 Sep
1550059418795578
A Novel Strategy to Identify Placebo Responders: Prediction Index of Clinical and Biological Markers in the EMBARC Trial.
Trivedi MH, South C, Jha MK, Rush AJ, Cao J, Kurian B, Phillips M, Pizzagalli DA, Trombello JM, Oquendo MA, Cooper C, Dillon DG, Webb C, Grannemann BD, Bruder G, McGrath PJ, Parsey R, Weissman M, Fava M
Psychotherapy and psychosomatics
2018 Aug
1-11
Do baseline sub-threshold hypomanic symptoms affect acute-phase antidepressant outcome in outpatients with major depressive disorder? Preliminary findings from the randomized CO-MED trial.
Jha MK, Malchow AL, Grannemann BD, Rush AJ, Trivedi MH
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
2018 Aug
Adiponectin Moderates Antidepressant Treatment Outcome in the Combining Medications to Enhance Depression Outcomes Randomized Clinical Trial.
Furman JL, Soyombo A, Czysz AH, Jha MK, Carmody TJ, Mason BL, Scherer PE, Trivedi MH,
Personalized medicine in psychiatry
2018 Aug-Sep
9-10
1-7
Development and evaluation of a multimodal marker of major depressive disorder.
Yang J, Zhang M, Ahn H, Zhang Q, Jin TB, Li IA, Nemesure M, Joshi N, Jiang H, Miller JM, Ogden RT, Petkova E, Milak MS, Sublette ME, Sullivan GM, Trivedi MH, Weissman M, McGrath PJ, Fava M, Kurian BT, Pizzagalli DA, Cooper CM, McInnis M, Oquendo MA, Mann JJ, Parsey RV, DeLorenzo C
Human brain mapping
2018 Aug
Improving the identification and treatment of depression in low-income primary care clinics: a qualitative study of providers in the VitalSign6 program.
Kahalnik F, Sanchez K, Faria A, Grannemann B, Jha M, Tovian C, Clark EW, Levinson S, Pipes R, Pederson M, Trivedi MH
International journal for quality in health care : journal of the International Society for Quality in Health Care
2018 Jul
Experimental Therapies for Treatment-Resistant Depression: "How do you decide when to go to an unproven or experimental therapy with patients that are treatment-resistant depression?"
Jha MK, Trivedi MH
Focus (American Psychiatric Publishing)
2018 Jul
16
279-284
Statistical harmonization corrects site effects in functional connectivity measurements from multi-site fMRI data.
Yu M, Linn KA, Cook PA, Phillips ML, McInnis M, Fava M, Trivedi MH, Weissman MM, Shinohara RT, Sheline YI
Human brain mapping
2018 Jul
Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study.
Webb CA, Trivedi MH, Cohen ZD, Dillon DG, Fournier JC, Goer F, Fava M, McGrath PJ, Weissman M, Parsey R, Adams P, Trombello JM, Cooper C, Deldin P, Oquendo MA, McInnis MG, Huys Q, Bruder G, Kurian BT, Jha M, DeRubeis RJ, Pizzagalli DA
Psychological medicine
2018 Jul
1-10
The Promoting Activity in Cancer Survivors (PACES) trial: a multiphase optimization of strategy approach to increasing physical activity in breast cancer survivors.
Rethorst CD, Hamann HA, Carmody TJ, Sharp KJ, Argenbright KE, Haley BB, Skinner CS, Trivedi MH
BMC cancer
2018 Jul
18
744
Association of Midlife Cardiorespiratory Fitness With Incident Depression and Cardiovascular Death After Depression in Later Life.
Willis BL, Leonard D, Barlow CE, Martin SB, DeFina LF, Trivedi MH
JAMA psychiatry
2018 Jun
Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder.
Bartlett EA, DeLorenzo C, Sharma P, Yang J, Zhang M, Petkova E, Weissman M, McGrath PJ, Fava M, Ogden RT, Kurian BT, Malchow A, Cooper CM, Trombello JM, McInnis M, Adams P, Oquendo MA, Pizzagalli DA, Trivedi M, Parsey RV
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
2018 Jun
A Complier Average Causal Effect Analysis of the Stimulant Reduction Intervention using Dosed Exercise Study.
Carmody T, Greer TL, Walker R, Rethorst CD, Trivedi MH
Contemporary clinical trials communications
2018 Jun
10
1-8
Association of Novel ALX4 Gene Polymorphisms with Antidepressant Treatment Response: Findings from the CO-MED Trial.
Gadad BS, Raj P, Jha MK, Carmody T, Dozmorov I, Mayes TL, Wakeland EK, Trivedi MH
Molecular neuropsychiatry
2018 Jun
7-19
Association of T and non-T cell cytokines with anhedonia: Role of gender differences.
Jha MK, Miller AH, Minhajuddin A, Trivedi MH
Psychoneuroendocrinology
2018 May
95
1-7
Pretreatment Rostral Anterior Cingulate Cortex Theta Activity in Relation to Symptom Improvement in Depression: A Randomized Clinical Trial.
Pizzagalli DA, Webb CA, Dillon DG, Tenke CE, Kayser J, Goer F, Fava M, McGrath P, Weissman M, Parsey R, Adams P, Trombello J, Cooper C, Deldin P, Oquendo MA, McInnis MG, Carmody T, Bruder G, Trivedi MH
JAMA psychiatry
2018 Apr
Characterizing anxiety subtypes and the relationship to behavioral phenotyping in major depression: Results from the EMBARC study.
Trombello JM, Pizzagalli DA, Weissman MM, Grannemann BD, Cooper CM, Greer TL, Malchow AL, Jha MK, Carmody TJ, Kurian BT, Webb CA, Dillon DG, McGrath PJ, Bruder G, Fava M, Parsey RV, McInnis MG, Adams P, Trivedi MH
Journal of psychiatric research
2018 Apr
102
207-215
A psychometric evaluation of the Concise Health Risk Tracking Self-Report (CHRT-SR)- a measure of suicidality-in patients with stimulant use disorder.
Sanchez K, Killian MO, Mayes TL, Greer TL, Trombello JM, Lindblad R, Grannemann BD, Carmody TJ, Rush AJ, Walker R, Trivedi MH
Journal of psychiatric research
2018 Mar
102
65-71
Psychometric properties of the concise health risk tracking (CHRT) in adolescents with suicidality.
Mayes TL, Kennard BD, Killian M, Carmody T, Grannemann BD, Rush AJ, Jha MK, Hughes J, Emslie GJ, Trivedi MH
Journal of affective disorders
2018 Mar
235
45-51
Antisuicidal Effects of Ketamine: A Promising First Step.
Trivedi MH
The American journal of psychiatry
2018 Feb
175
97-98
Validating pre-treatment body mass index as moderator of antidepressant treatment outcomes: Findings from CO-MED trial.
Jha MK, Wakhlu S, Dronamraju N, Minhajuddin A, Greer TL, Trivedi MH
Journal of affective disorders
2018 Feb
234
34-37
Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation.
Jha MK, Trivedi MH
International journal of molecular sciences
2018 Jan
19
Psychometrics of the Self-Report Concise Associated Symptoms Tracking Scale (CAST-SR): Results From the STRIDE (CTN-0037) Study.
Trombello JM, Killian MO, Liao A, Sanchez K, Greer TL, Walker R, Grannemann B, Rethorst CD, Carmody T, Trivedi MH
The Journal of clinical psychiatry
2018 Jan
79
Harmonization of cortical thickness measurements across scanners and sites.
Fortin JP, Cullen N, Sheline YI, Taylor WD, Aselcioglu I, Cook PA, Adams P, Cooper C, Fava M, McGrath PJ, McInnis M, Phillips ML, Trivedi MH, Weissman MM, Shinohara RT
NeuroImage
2017 Nov
167
104-120
Worsening Anxiety, Irritability, Insomnia, or Panic Predicts Poorer Antidepressant Treatment Outcomes: Clinical Utility and Validation of the Concise Associated Symptom Tracking (CAST) Scale.
Jha MK, Minhajuddin A, South C, Rush AJ, Trivedi MH
The international journal of neuropsychopharmacology
2017 Nov
Immune-based strategies for mood disorders: facts and challenges.
Colpo GD, Leboyer M, Dantzer R, Trivedi MH, Teixeira AL
Expert review of neurotherapeutics
2017 Nov
1-14
Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.
Hedayati SS, Gregg LP, Carmody T, Jain N, Toups M, Rush AJ, Toto RD, Trivedi MH
JAMA
2017 11
318
19
1876-1890
Efficacy of a Behavioral Activation Teletherapy Intervention to Treat Depression and Anxiety in Primary Care VitalSign6 Program.
Trombello JM, South C, Cecil A, Sánchez KE, Sánchez AC, Eidelman SL, Mayes TL, Kahalnik F, Tovian C, Kennard BD, Trivedi MH
The primary care companion for CNS disorders
2017 Oct
19
Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement.
Dodd S, Mitchell PB, Bauer M, Yatham L, Young AH, Kennedy SH, Williams L, Suppes T, Lopez Jaramillo C, Trivedi MH, Fava M, Rush AJ, McIntyre RS, Thase ME, Lam RW, Severus E, Kasper S, Berk M
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
2017 Oct
1-19
Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD).
Fava M, Freeman MP, Flynn M, Hoeppner BB, Shelton R, Iosifescu DV, Murrough JW, Mischoulon D, Cusin C, Rapaport M, Dunlop BW, Trivedi MH, Jha M, Sanacora G, Hermes G, Papakostas GI
Brain stimulation
2017 Sep
Psychopharmacological Treatment in the RAISE-ETP Study: Outcomes of a Manual and Computer Decision Support System Based Intervention.
Robinson DG, Schooler NR, Correll CU, John M, Kurian BT, Marcy P, Miller AL, Pipes R, Trivedi MH, Kane JM
The American journal of psychiatry
2017 Sep
appiajp201716080919
Test-retest reliability of cerebral blood flow in healthy individuals using arterial spin labeling: Findings from the EMBARC study.
Almeida JRC, Greenberg T, Lu H, Chase HW, Fournier J, Cooper CM, Deckersbach T, Adams P, Carmody T, Fava M, Kurian B, McGrath PJ, McInnis MG, Oquendo MA, Parsey R, Weissman M, Trivedi M, Phillips ML
Magnetic resonance imaging
2017 Sep
45
26-33
Cortical thickness is not associated with current depression in a clinical treatment study.
Perlman G, Bartlett E, DeLorenzo C, Weissman M, McGrath P, Ogden T, Jin T, Adams P, Trivedi M, Kurian B, Oquendo M, McInnis M, Weyandt S, Fava M, Cooper C, Malchow A, Parsey R,
Human brain mapping
2017 09
38
4370-4385
Measurement, Education and Tracking in Integrated Care (METRIC): use of a culturally adapted education tool versus standard education to increase engagement in depression treatment among Hispanic patients: study protocol for a randomized control trial.
Sanchez K, Eghaneyan BH, Killian MO, Cabassa L, Trivedi MH
Trials
2017 Aug
18
363
Prediction of treatment outcomes to exercise in patients with nonremitted major depressive disorder.
Rethorst CD, South CC, Rush AJ, Greer TL, Trivedi MH
Depression and anxiety
2017 Jul
Evaluation of the benefits of exercise on cognition in major depressive disorder.
Greer TL, Furman JL, Trivedi MH
General hospital psychiatry
2017 Jul
Cardiorespiratory fitness and body composition of stimulant users: A baseline analysis of the STRIDE cohort.
Stoutenberg M, Rethorst CD, Vidot DC, Greer TL, Trivedi MH
Journal of substance abuse treatment
2017 Jul
78
74-79
Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection.
Jha MK, Minhajuddin A, Gadad BS, Greer TL, Mayes TL, Trivedi MH
Brain, behavior, and immunity
2017 Jul
Trajectories of suicidal ideation over 6 months among 482 outpatients with bipolar disorder.
Köhler-Forsberg O, Madsen T, Behrendt-Møller I, Sylvia L, Bowden CL, Gao K, Bobo WV, Trivedi MH, Calabrese JR, Thase M, Shelton RC, McInnis M, Tohen M, Ketter TA, Friedman ES, Deckersbach T, McElroy SL, Reilly-Harrington NA, Nierenberg AA
Journal of affective disorders
2017 Jul
223
146-152
Pilot investigation into the sickness response to influenza vaccination in adults: Effect of depression and anxiety.
Harper JA, South C, Trivedi MH, Toups MS
General hospital psychiatry
2017 Jul
48
56-61
Platelet-Derived Growth Factor as an Antidepressant Treatment Selection Biomarker: Higher Levels Selectively Predict Better Outcomes with Bupropion-SSRI Combination.
Jha MK, Minhajuddin A, Gadad BS, Trivedi MH
The international journal of neuropsychopharmacology
2017 Jul
Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks.
Gadad BS, Jha MK, Czysz A, Furman JL, Mayes TL, Emslie MP, Trivedi MH
Journal of affective disorders
2017 Jul
Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive Disorder.
Connor KM, Ceesay P, Hutzlemann J, Snavely D, Krystal AD, Trivedi MH, Thase M, Lines C, Herring WJ, Michelson D
The international journal of neuropsychopharmacology
2017 Jun
Statistical Analysis Plan for Stage 1 EMBARC (Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care) Study.
Petkova E, Ogden RT, Tarpey T, Ciarleglio A, Jiang B, Su Z, Carmody T, Adams P, Kraemer HC, Grannemann BD, Oquendo MA, Parsey R, Weissman M, McGrath PJ, Fava M, Trivedi MH
Contemporary clinical trials communications
2017 Jun
22-30
Proteomics profiling reveals inflammatory biomarkers of antidepressant treatment response: Findings from the CO-MED trial.
Gadad BS, Jha MK, Grannemann BD, Mayes TL, Trivedi MH
Journal of psychiatric research
2017 May
94
1-6
Racial and ethnic differences in treatment outcomes among adults with stimulant use disorders after a dosed exercise intervention.
Sanchez K, Greer TL, Walker R, Carmody T, Rethorst CD, Trivedi MH
Journal of ethnicity in substance abuse
2017 May
1-16
Is C-reactive protein ready for prime time in the selection of antidepressant medications?
Miller AH, Trivedi MH, Jha MK
Psychoneuroendocrinology
2017 Apr
Psychosocial relationship status and quality as predictors of exercise intervention adherence and substance use outcomes: Results from the STRIDE (CTN-0037) study.
Trombello JM, Carmody T, Greer TL, Walker R, Rethorst CD, Trivedi MH
Psychiatry research
2017 Apr
254
332-339
Effects of depression, metabolic syndrome, and cardiorespiratory fitness on mortality: results from the Cooper Center Longitudinal Study.
Rethorst CD, Leonard D, Barlow CE, Willis BL, Trivedi MH, DeFina LF
Psychological medicine
2017 Apr
1-7
A pilot program for implementing mental health screening, assessment, and navigation in a community-based cancer center.
Howe-Martin L, Jester B, Walker R, de la Garza N, Jha MK, Tovian C, Levinson S, Argenbright KE, Trivedi MH
Psycho-oncology
2017 Mar
Toward a very brief self-report to assess the core symptoms of depression (VQIDS-SR5 ).
De La Garza N, John Rush A, Grannemann BD, Trivedi MH
Acta psychiatrica Scandinavica
2017 Mar
Neuroticism and Individual Differences in Neural Function in Unmedicated Major Depression: Findings from the EMBARC Study.
Fournier JC, Chase HW, Greenberg T, Etkin A, Almeida JR, Stiffler R, Deckersbach T, Weyandt S, Cooper C, Toups M, Carmody T, Kurian B, Peltier S, Adams P, McInnis MG, Oquendo MA, McGrath PJ, Fava M, Weissman M, Parsey R, Trivedi MH, Phillips ML
Biological psychiatry. Cognitive neuroscience and neuroimaging
2017 Mar
138-148
Randomized Controlled Trial Comparing Exercise to Health Education for Stimulant Use Disorder: Results From the CTN-0037 STimulant Reduction Intervention Using Dosed Exercise (STRIDE) Study.
Trivedi MH, Greer TL, Rethorst CD, Carmody T, Grannemann BD, Walker R, Warden D, Shores-Wilson K, Stoutenberg M, Oden N, Silverstein M, Hodgkins C, Love L, Seamans C, Stotts A, Causey T, Szucs-Reed RP, Rinaldi P, Myrick H, Straus M, Liu D, Lindblad R, Church T, Blair SN, Nunes EV
The Journal of clinical psychiatry
2017 Feb
Exercise is an effective treatment for positive valence symptoms in major depression.
Toups M, Carmody T, Greer T, Rethorst C, Grannemann B, Trivedi MH
Journal of affective disorders
2017 Feb
209
188-194
Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach.
Chekroud AM, Gueorguieva R, Krumholz HM, Trivedi MH, Krystal JH, McCarthy G
JAMA psychiatry
2017 Feb
Accurately identifying patients who are excellent candidates or unsuitable for a medication: a novel approach.
South C, Rush AJ, Carmody TJ, Jha MK, Trivedi MH
Neuropsychiatric disease and treatment
2017
13
3001-3010
Harmonization of cortical thickness measurements across scanners and sites
Fortin, Jean-Philippe Cullen, Nicholas Sheline, Yvette Taylor, Warren Aselcioglu, Irem Adams, Phil Cooper, Crystal Fava, Maurizio McGrath, Patrick McInnis, Melvin Parsey, Ramin Phillips, Mary Trivedi, Madhukar Weissman, Myrna Shinohara, Russell
NeuroImage
2017
167
104-120
Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial.
Jha MK, Minhajuddin A, Gadad BS, Greer T, Grannemann B, Soyombo A, Mayes TL, Rush AJ, Trivedi MH
Psychoneuroendocrinology
2017 Jan
78
105-113
A comparison of structural connectivity in anxious depression versus non-anxious depression.
Delaparte L, Yeh FC, Adams P, Malchow A, Trivedi MH, Oquendo MA, Deckersbach T, Ogden T, Pizzagalli DA, Fava M, Cooper C, McInnis M, Kurian BT, Weissman MM, McGrath PJ, Klein DN, Parsey RV, DeLorenzo C
Journal of psychiatric research
2017 Jan
89
38-47
Side Effects to Antidepressant Treatment in Patients With Depression and Comorbid Panic Disorder.
Shankman SA, Gorka SM, Katz AC, Klein DN, Markowitz JC, Arnow BA, Manber R, Rothbaum BO, Thase ME, Schatzberg AF, Keller MB, Trivedi MH, Kocsis JH
The Journal of clinical psychiatry
2017 Jan
Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder.
Jha MK, Teer RB, Minhajuddin A, Greer TL, Rush AJ, Trivedi MH
Neuropsychiatric disease and treatment
2017
13
803-813
Demonstrating test-retest reliability of electrophysiological measures for healthy adults in a multisite study of biomarkers of antidepressant treatment response.
Tenke CE, Kayser J, Pechtel P, Webb CA, Dillon DG, Goer F, Murray L, Deldin P, Kurian BT, McGrath PJ, Parsey R, Trivedi M, Fava M, Weissman MM, McInnis M, Abraham K, E Alvarenga J, Alschuler DM, Cooper C, Pizzagalli DA, Bruder GE,
Psychophysiology
2017 01
54
34-50
Neurospora sp. SR8, a novel phosphate solubiliser from rhizosphere soil of Sorghum in Kachchh, Gujarat, India.
Sharma SB, Sayyed RZ, Sonawane M, Trivedi MH, Thivakaran GA
Indian journal of experimental biology
2016 Oct
54
10
644-649
Right patient, right treatment, right time: biosignatures and precision medicine in depression.
Trivedi MH
World psychiatry : official journal of the World Psychiatric Association (WPA)
2016 Oct
15
237-238
Death by Insulin: Management of Self-Harm and Suicide in Diabetes Management.
Myers A, Trivedi MH
Current diabetes reviews
2016 Oct
Performance of depression rating scales in patients with chronic kidney disease: an item response theory-based analysis.
Toups M, Carmody T, Trivedi MH, Rush AJ, Hedayati SS
General hospital psychiatry
2016 Sep-Oct
42
60-6
Demographic and clinical characteristics of current comorbid psychiatric disorders in a randomized clinical trial for adults with stimulant use disorders.
Warden D, Sanchez K, Greer T, Carmody T, Walker R, Dela Cruz A, Toups M, Rethorst C, Trivedi MH
Psychiatry research
2016 Sep
246
136-141
Affect Following First Exercise Session as a Predictor of Treatment Response in Depression.
Suterwala AM, Rethorst CD, Carmody TJ, Greer TL, Grannemann BD, Jha M, Trivedi MH
The Journal of clinical psychiatry
2016 Aug
77
1036-42
Atypical depressive symptoms as a predictor of treatment response to exercise in Major Depressive Disorder.
Rethorst CD, Tu J, Carmody TJ, Greer TL, Trivedi MH
Journal of affective disorders
2016 Aug
200
156-8
Early Improvement in Work Productivity Predicts Future Clinical Course in Depressed Outpatients: Findings From the CO-MED Trial.
Jha MK, Minhajuddin A, Greer TL, Carmody T, Rush AJ, Trivedi MH
The American journal of psychiatry
2016 Aug
appiajp201616020176
An ounce of prevention: A pre-randomization protocol to improve retention in substance use disorder clinical trials.
Northrup TF, Greer TL, Walker R, Rethorst CD, Warden D, Stotts AL, Trivedi MH
Addictive behaviors
2016 Aug
64
137-142
Early normalization of Quality of Life predicts later remission in depression: Findings from the CO-MED trial.
Jha MK, Greer TL, Grannemann BD, Carmody T, Rush AJ, Trivedi MH
Journal of affective disorders
2016 Jul
206
17-22
IMPROVEMENTS IN PSYCHOSOCIAL FUNCTIONING AND HEALTH-RELATED QUALITY OF LIFE FOLLOWING EXERCISE AUGMENTATION IN PATIENTS WITH TREATMENT RESPONSE BUT NONREMITTED MAJOR DEPRESSIVE DISORDER: RESULTS FROM THE TREAD STUDY.
Greer TL, Trombello JM, Rethorst CD, Carmody TJ, Jha MK, Liao A, Grannemann BD, Chambliss HO, Church TS, Trivedi MH
Depression and anxiety
2016 May
Baseline medical comorbidities in adults randomized in the STRIDE trial for psychostimulant use disorders.
Dela Cruz AM, Carmody T, Greer TL, Rethorst CD, Warden D, Walker R, Trivedi MH
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions
2016 Apr
25
215-20
A tool to predict suicidal ideation and behavior in bipolar disorder: The Concise Health Risk Tracking Self-Report.
Reilly-Harrington NA, Shelton RC, Kamali M, Rabideau DJ, Shesler LW, Trivedi MH, McElroy SL, Sylvia LG, Bowden CL, Ketter TA, Calabrese JR, Thase ME, Bobo WV, Deckersbach T, Tohen M, McInnis MG, Kocsis JH, Gold AK, Singh V, Finkelstein DM, Kinrys G, Nierenberg AA
Journal of affective disorders
2016 Mar
192
212-8
Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design.
Trivedi MH, McGrath PJ, Fava M, Parsey RV, Kurian BT, Phillips ML, Oquendo MA, Bruder G, Pizzagalli D, Toups M, Cooper C, Adams P, Weyandt S, Morris DW, Grannemann BD, Ogden RT, Buckner R, McInnis M, Kraemer HC, Petkova E, Carmody TJ, Weissman MM
Journal of psychiatric research
2016 Mar
78
11-23
Dose Response for SSRIs.
Trivedi MH
The American journal of psychiatry
2016 Feb
173
105-6
Understanding the Impact of Treatment on the Dimensions of Childhood Depression.
Isa A, Bernstein I, Trivedi M, Mayes T, Kennard B, Emslie G
Journal of child and adolescent psychopharmacology
2016 Feb
Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial.
Fava M, Memisoglu A, Thase ME, Bodkin JA, Trivedi MH, de Somer M, Du Y, Leigh-Pemberton R, DiPetrillo L, Silverman B, Ehrich E
The American journal of psychiatry
2016 Feb
appiajp201515070921
Prognostic Utility of a Self-Reported Depression Questionnaire versus Clinician-Based Assessment on Renal Outcomes.
Jain N, Carmody T, Minhajuddin AT, Toups M, Trivedi MH, Rush AJ, Hedayati SS
American journal of nephrology
2016
44
234-44
Depression Screening and Education: Options to Reduce Barriers to Treatment (DESEO): protocol for an educational intervention study.
Sanchez K, Eghaneyan BH, Trivedi MH
BMC health services research
2016
16
322
Cross-trial prediction of treatment outcome in depression: a machine learning approach.
Chekroud AM, Zotti RJ, Shehzad Z, Gueorguieva R, Johnson MK, Trivedi MH, Cannon TD, Krystal JH, Corlett PR
The lancet. Psychiatry
2016 Jan
Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients.
Jha MK, Minhajuddin A, Greer TL, Carmody T, Rush AJ, Trivedi MH
PloS one
2016
11
12
e0167901
Prevalence and impact of obsessive-compulsive symptoms in depression: a STAR*D report.
Baer L, Trivedi MH, Huz I, Rush AJ, Wisniewski SR, Fava M
The Journal of clinical psychiatry
2015 Dec
76
12
1668-74
Rationale and design of A Trial of Sertraline vs. Cognitive Behavioral Therapy for End-stage Renal Disease Patients with Depression (ASCEND).
Hedayati SS, Daniel DM, Cohen S, Comstock B, Cukor D, Diaz-Linhart Y, Dember LM, Dubovsky A, Greene T, Grote N, Heagerty P, Katon W, Kimmel PL, Kutner N, Linke L, Quinn D, Rue T, Trivedi MH, Unruh M, Weisbord S, Young BA, Mehrotra R
Contemporary clinical trials
2015 Nov
47
1-11
A COMPREHENSIVE EXAMINATION OF WHITE MATTER TRACTS AND CONNECTOMETRY IN MAJOR DEPRESSIVE DISORDER.
Olvet DM, Delaparte L, Yeh FC, DeLorenzo C, McGrath PJ, Weissman MM, Adams P, Fava M, Deckersbach T, McInnis MG, Carmody TJ, Cooper CM, Kurian BT, Lu H, Toups MS, Trivedi MH, Parsey RV
Depression and anxiety
2015 Oct
A clinical measure of suicidal ideation, suicidal behavior, and associated symptoms in bipolar disorder: Psychometric properties of the Concise Health Risk Tracking Self-Report (CHRT-SR).
Ostacher MJ, Nierenberg AA, Rabideau D, Reilly-Harrington NA, Sylvia LG, Gold AK, Shesler LW, Ketter TA, Bowden CL, Calabrese JR, Friedman ES, Iosifescu DV, Thase ME, Leon AC, Trivedi MH
Journal of psychiatric research
2015 Oct
71
126-133
Moderation of the Relationship Between Reward Expectancy and Prediction Error-Related Ventral Striatal Reactivity by Anhedonia in Unmedicated Major Depressive Disorder: Findings From the EMBARC Study.
Greenberg T, Chase HW, Almeida JR, Stiffler R, Zevallos CR, Aslam HA, Deckersbach T, Weyandt S, Cooper C, Toups M, Carmody T, Kurian B, Peltier S, Adams P, McInnis MG, Oquendo MA, McGrath PJ, Fava M, Weissman M, Parsey R, Trivedi MH, Phillips ML
The American journal of psychiatry
2015 Jul
appiajp201514050594
Neural Correlates of Three Promising Endophenotypes of Depression: Evidence from the EMBARC Study.
Webb CA, Dillon DG, Pechtel P, Goer FK, Murray L, Huys QJ, Fava M, McGrath PJ, Weissman M, Parsey R, Kurian BT, Adams P, Weyandt S, Trombello JM, Grannemann B, Cooper CM, Deldin P, Tenke C, Trivedi M, Bruder G, Pizzagalli DA
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
2015 Jun
A randomized, double-blind, placebo-controlled study of the efficacy and safety of vortioxetine 10 mg and 20 mg in adults with major depressive disorder.
Jacobsen PL, Mahableshwarkar AR, Serenko M, Chan S, Trivedi MH
The Journal of clinical psychiatry
2015 May
76
575-82
A randomized, double-blind, placebo-controlled study of the efficacy and safety of 2 doses of vortioxetine in adults with major depressive disorder.
Mahableshwarkar AR, Jacobsen PL, Serenko M, Chen Y, Trivedi MH
The Journal of clinical psychiatry
2015 May
76
583-91
Test-retest reliability of freesurfer measurements within and between sites: Effects of visual approval process.
Iscan Z, Jin TB, Kendrick A, Szeglin B, Lu H, Trivedi M, Fava M, McGrath PJ, Weissman M, Kurian BT, Adams P, Weyandt S, Toups M, Carmody T, McInnis M, Cusin C, Cooper C, Oquendo MA, Parsey RV, DeLorenzo C
Human brain mapping
2015 May
A computational analysis of flanker interference in depression.
Dillon DG, Wiecki T, Pechtel P, Webb C, Goer F, Murray L, Trivedi M, Fava M, McGrath PJ, Weissman M, Parsey R, Kurian B, Adams P, Carmody T, Weyandt S, Shores-Wilson K, Toups M, McInnis M, Oquendo MA, Cusin C, Deldin P, Bruder G, Pizzagalli DA
Psychological medicine
2015 Mar
1-12
On the invariance of the Stimulant Craving Questionnaire (STCQ) across cocaine and methamphetamine users.
Northrup TF, Green C, Walker R, Greer TL, Trivedi MH
Addictive behaviors
2015 Mar
42
144-7
Evaluation of anhedonia with the Snaith-Hamilton Pleasure Scale (SHAPS) in adult outpatients with major depressive disorder.
Nakonezny PA, Morris DW, Greer TL, Byerly MJ, Carmody TJ, Grannemann BD, Bernstein IH, Trivedi MH
Journal of psychiatric research
2015 Mar
Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entry.
Chartier KG, Sanchez K, Killeen TK, Burrow A, Carmody T, Greer TL, Trivedi MH
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions
2015 Feb
Opioid withdrawal, craving, and use during and after outpatient buprenorphine stabilization and taper: a discrete survival and growth mixture model.
Northrup TF, Stotts AL, Green C, Potter JS, Marino EN, Walker R, Weiss RD, Trivedi M
Addictive behaviors
2015 Feb
41
20-8
Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches.
Phillips ML, Chase HW, Sheline YI, Etkin A, Almeida JR, Deckersbach T, Trivedi MH
The American journal of psychiatry
2015 Feb
172
124-38
Comorbidities and Race/Ethnicity Among Adults with Stimulant Use Disorders in Residential Treatment.
Sanchez K, Chartier KG, Greer TL, Walker R, Carmody T, Rethorst CD, Ring KM, Dela Cruz AM, Trivedi MH
Journal of ethnicity in substance abuse
2015 Jan
1-17
A randomized, double-blind, duloxetine-referenced study comparing efficacy and tolerability of 2 fixed doses of vortioxetine in the acute treatment of adults with MDD.
Mahableshwarkar AR, Jacobsen PL, Chen Y, Serenko M, Trivedi MH
Psychopharmacology
2015 Jan
Accounting for Dynamic Fluctuations across Time when Examining fMRI Test-Retest Reliability: Analysis of a Reward Paradigm in the EMBARC Study.
Chase HW, Fournier JC, Greenberg T, Almeida JR, Stiffler R, Zevallos CR, Aslam H, Cooper C, Deckersbach T, Weyandt S, Adams P, Toups M, Carmody T, Oquendo MA, Peltier S, Fava M, McGrath PJ, Weissman M, Parsey R, McInnis MG, Kurian B, Trivedi MH, Phillips ML
PloS one
2015
10
e0126326
Opioid addiction screening tools for patients with chronic noncancer pain.
Dela Cruz AM, Trivedi MH
Texas medicine
2015
111
61-5
IL-1? and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder.
Rethorst CD, Greer TL, Toups MS, Bernstein I, Carmody TJ, Trivedi MH
Translational psychiatry
2015
e611
Inflammation, obesity, and metabolic syndrome in depression: analysis of the 2009-2010 National Health and Nutrition Examination Survey (NHANES).
Rethorst CD, Bernstein I, Trivedi MH
The Journal of clinical psychiatry
2014 Dec
75
12
e1428-32
ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression.
Ray A, Tennakoon L, Keller J, Sarginson JE, Ryan HS, Murphy GM, Lazzeroni LC, Trivedi MH, Kocsis JH, DeBattista C, Schatzberg AF
The pharmacogenomics journal
2014 Dec
Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: A CO-MED report.
Sung SC, Wisniewski SR, Luther JF, Trivedi MH, Rush AJ
Journal of affective disorders
2014 Nov
174C
157-164
Dose-dependent changes in cognitive function with exercise augmentation for major depression: Results from the TREAD study.
Greer TL, Grannemann BD, Chansard M, Karim AI, Trivedi MH
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
2014 Oct
Childhood Depression Subscales Using Repeated Sessions on Children's Depression Rating Scale - Revised (CDRS-R) Scores.
Isa A, Bernstein I, Trivedi M, Mayes T, Kennard B, Emslie G
Journal of child and adolescent psychopharmacology
2014 Aug
24
318-24
Self-rated measure of pain frequency, intensity, and burden: Psychometric properties of a new instrument for the assessment of pain.
Dela Cruz AM, Bernstein IH, Greer TL, Walker R, Rethorst CD, Grannemann B, Carmody T, Trivedi MH
Journal of psychiatric research
2014 Aug
Depressive Symptoms and Associated Clinical Characteristics in Outpatients Seeking Community-based Treatment for Alcohol and Drug Problems.
Sanchez K, Walker R, Campbell AN, Greer TL, Hu MC, Grannemann BD, Nunes EV, Trivedi MH
Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse
2014 Aug
Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: Implications for the Research Domain Criteria (RDoC).
Ostergaard SD, Bech P, Trivedi MH, Wisniewski SR, Rush AJ, Fava M
Journal of affective disorders
2014 Jul
163
18-24
A Health Education Intervention as the Control Condition in the CTN-0037 STRIDE multi-site exercise trial: Rationale and Description.
Rethorst CD, Greer TL, Grannemann B, Ring KM, Marcus BH, Trivedi MH
Mental health and physical activity
2014 Mar
37-41
Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
Warden D, Trivedi MH, Carmody T, Toups M, Zisook S, Lesser I, Myers A, Kurian KR, Morris D, Rush AJ
Journal of psychiatric practice
2014 Mar
20
118-32
Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram.
Svenningsson P, Berg L, Matthews D, Ionescu DF, Richards EM, Niciu MJ, Malinger A, Toups M, Manji H, Trivedi MH, Zarate CA, Greengard P
Molecular psychiatry
2014 Mar
Does duloxetine improve cognitive function independently of its antidepressant effect in patients with major depressive disorder and subjective reports of cognitive dysfunction?
Greer TL, Sunderajan P, Grannemann BD, Kurian BT, Trivedi MH
Depression research and treatment
2014
2014
627863
Cognitive dysfunction in unipolar depression: implications for treatment.
Trivedi MH, Greer TL
Journal of affective disorders
2014 Jan
152-154
19-27
Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the prevent study.
Kornstein SG, Pedersen RD, Holland PJ, Nemeroff CB, Rothschild AJ, Thase ME, Trivedi MH, Ninan PT, Keller MB
The Journal of clinical psychiatry
2014 Jan
75
62-8
Research staff training in a multisite randomized clinical trial: Methods and recommendations from the Stimulant Reduction Intervention using Dosed Exercise (STRIDE) trial.
Walker R, Morris DW, Greer TL, Trivedi MH
Addiction research & theory
2014
22
407-415
Lisdexamfetamine Dimesylate Augmentation in Adults With Persistent Executive Dysfunction After Partial or Full Remission of Major Depressive Disorder.
Madhoo M, Keefe RS, Roth RM, Sambunaris A, Wu J, Trivedi MH, Anderson CS, Lasser R
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
2013 Dec
Brief report: depression and history of suicide attempts in adults with new-onset Type 2 Diabetes.
Myers AK, Grannemann BD, Lingvay I, Trivedi MH
Psychoneuroendocrinology
2013 Nov
38
11
2810-4
Relationship between obesity and depression: characteristics and treatment outcomes with antidepressant medication.
Toups MS, Myers AK, Wisniewski SR, Kurian B, Morris DW, Rush AJ, Fava M, Trivedi MH
Psychosomatic medicine
2013 Nov-Dec
75
863-72
A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram.
Trivedi MH, Cutler AJ, Richards C, Lasser R, Geibel BB, Gao J, Sambunaris A, Patkar AA
The Journal of clinical psychiatry
2013 Aug
74
802-9
Response to Stanton, Reaburn, and Rosenbaum.
Rethorst CD, Trivedi MH
Journal of psychiatric practice
2013 Jul
19
272-3
Sustaining practice change one year after completion of the national depression management leadership initiative.
Chung H, Duffy FF, Katzelnick DJ, Williams MD, Trivedi MH, Rae DS, Regier DA
Psychiatric services (Washington, D.C.)
2013 Jul
64
703-6
Modeling predictors, moderators and mediators of treatment outcome and resistance in depression.
Trivedi MH
Biological psychiatry
2013 Jul
74
2-4
Evaluating and monitoring treatment response in depression using measurement-based assessment and rating scales.
Trivedi MH
The Journal of clinical psychiatry
2013 Jul
74
e14
Increase in work productivity of depressed individuals with improvement in depressive symptom severity.
Trivedi MH, Morris DW, Wisniewski SR, Lesser I, Nierenberg AA, Daly E, Kurian BT, Gaynes BN, Balasubramani GK, Rush AJ
The American journal of psychiatry
2013 Jun
170
633-41
Quetiapine XR monotherapy in major depressive disorder: a pooled analysis to assess the influence of baseline severity on efficacy.
Thase ME, Montgomery S, Papakostas GI, Bauer M, Trivedi MH, Svedsäter H, Locklear JC, Gustafsson U, Datto C, Eriksson H
International clinical psychopharmacology
2013 May
28
113-120
Evaluation of the effects of extended release quetiapine fumarate monotherapy on sleep disturbance in patients with major depressive disorder: a pooled analysis of four randomized acute studies.
Trivedi MH, Bandelow B, Demyttenaere K, Papakosts GI, Szamosi J, Earley W, Eriksson H
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)
2013 May
1-12
Evidence-based recommendations for the prescription of exercise for major depressive disorder.
Rethorst CD, Trivedi MH
Journal of psychiatric practice
2013 May
19
204-12
The Clinical Relevance of Self-Reported Premenstrual Worsening of Depressive Symptoms in the Management of Depressed Outpatients: A STAR*D Report.
Haley CL, Sung SC, Rush AJ, Trivedi MH, Wisniewski SR, Luther JF, Kornstein SG
Journal of women's health (2002)
2013 Mar
22
219-29
Clinical and sociodemographic characteristics associated with suicidal ideation in depressed outpatients.
Trivedi MH, Morris DW, Wisniewski SR, Nierenberg AA, Gaynes BN, Kurian BT, Warden D, Stegman D, Shores-Wilson K, Rush AJ
Canadian journal of psychiatry. Revue canadienne de psychiatrie
2013 Feb
58
113-22
Do Menopausal Status and Use of Hormone Therapy Affect Antidepressant Treatment Response? Findings from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study.
Kornstein SG, Toups M, Rush AJ, Wisniewski SR, Thase ME, Luther J, Warden D, Fava M, Trivedi MH
Journal of women's health (2002)
2013 Feb
22
121-31
Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial.
Cook IA, Hunter AM, Gilmer WS, Iosifescu DV, Zisook S, Burgoyne KS, Howland RH, Trivedi MH, Jain R, Greenwald S, Leuchter AF
The Journal of clinical psychiatry
2013 Jan
74
51-6
Using measurement-based care with patient involvement to improve outcomes in depression.
Culpepper L, Trivedi MH
The primary care companion to CNS disorders
2013
15
Cognitive and Psychosocial Improvements Following Aripiprazole Augmentation of SSRI Antidepressant Therapy in Treatment Refractory Depression: A Pilot Study
T. L. Greer, P. Sunderajan, B. Grannemann and M. H. Trivedi
Open Journal of Depression
2013
45-53
Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST).
Jain N, Trivedi MH, Rush AJ, Carmody T, Kurian B, Toto RD, Sarode R, Hedayati SS
Contemporary clinical trials
2013 Jan
34
136-44
Phosphate solubilizing microbes: sustainable approach for managing phosphorus deficiency in agricultural soils.
Sharma SB, Sayyed RZ, Trivedi MH, Gobi TA
SpringerPlus
2013
587
Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED Trial Report.
Sung SC, Wisniewski SR, Balasubramani GK, Zisook S, Kurian B, Warden D, Trivedi MH, Rush AJ
Psychological medicine
2012 Dec
1-16
STimulant Reduction Intervention using Dosed Exercise (STRIDE) - Description of the Exercise Intervention and Behavioral Program to Ensure Adherence.
Stoutenberg M, Rethorst C, Fuzat G, Greer T, Blair S, Church T, Marcus B, Trivedi M
Mental health and physical activity
2012 Dec
175-182
Neural correlates of successful response inhibition in unmedicated patients with late-life depression.
Bobb DS, Adinoff B, Laken SJ, McClintock SM, Rubia K, Huang HW, Husain MM, Mapes KS, Tamminga C, Cullum CM, Gopinath K, Trivedi MH, Kozel FA
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
2012 Dec
20
12
1057-69
Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED report.
Chan HN, Rush AJ, Nierenberg AA, Trivedi M, Wisniewski SR, Balasubramani GK, Friedman ES, Gaynes BN, Davis L, Morris D, Fava M,
The international journal of neuropsychopharmacology
2012 Nov
15
10
1387-99
Decline in cardiorespiratory fitness and odds of incident depression.
Dishman RK, Sui X, Church TS, Hand GA, Trivedi MH, Blair SN
American journal of preventive medicine
2012 Oct
43
361-8
Testing the efficacy of quercetin in mitigating bisphenol A toxicity in liver and kidney of mice.
Sangai NP, Verma RJ, Trivedi MH
Toxicology and industrial health
2012 Sep
Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth.
Warden D, Subramaniam GA, Carmody T, Woody GE, Minhajuddin A, Poole SA, Potter J, Fishman M, Bogenschutz M, Patkar A, Trivedi MH
Addictive behaviors
2012 Sep
37
1046-53
Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder.
Rethorst CD, Toups MS, Greer TL, Nakonezny PA, Carmody TJ, Grannemann BD, Huebinger RM, Barber RC, Trivedi MH
Molecular psychiatry
2012 Aug
Does exercise improve self-reported sleep quality in non-remitted major depressive disorder?
Rethorst CD, Sunderajan P, Greer TL, Grannemann BD, Nakonezny PA, Carmody TJ, Trivedi MH
Psychological medicine
2012 Aug
1-11
Feasible evidence-based strategies to manage depression in primary care.
Kurian BT, Grannemann B, Trivedi MH
Current psychiatry reports
2012 Aug
14
370-5
The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
Sung SC, Haley CL, Wisniewski SR, Fava M, Nierenberg AA, Warden D, Morris DW, Kurian BT, Trivedi MH, Rush AJ
The Journal of clinical psychiatry
2012 Jul
73
967-76
Exercise and mental illness: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
Dakwar E, Blanco C, Lin KH, Liu SM, Warden D, Trivedi M, Nunes EV,
The Journal of clinical psychiatry
2012 Jul
73
960-6
Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report.
Rush AJ, Wisniewski SR, Zisook S, Fava M, Sung SC, Haley CL, Chan HN, Gilmer WS, Warden D, Nierenberg AA, Balasubramani GK, Gaynes BN, Trivedi MH, Hollon SD
Psychological medicine
2012 Jun
42
1131-49
Biomarkers and the Future of Treatment for Depression.
Toups M, Trivedi MH
Cerebrum : the Dana forum on brain science
2012 5
2012
Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial.
Bech P, Fava M, Trivedi MH, Wisniewski SR, Rush AJ
Acta psychiatrica Scandinavica
2012 Apr
125
342-8
Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.
Friedman ES, Davis LL, Zisook S, Wisniewski SR, Trivedi MH, Fava M, Rush AJ
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
2012 Mar
22
183-99
What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression?
Gollan JK, Fava M, Kurian B, Wisniewski SR, Rush AJ, Daly E, Miyahara S, Trivedi MH
Depression and anxiety
2012 Feb
29
94-101
Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial.
Davis LL, Pilkinton P, Wisniewski SR, Trivedi MH, Gaynes BN, Howland RH, Zisook S, Balasubramani GK, Fava M, Rush AJ
Depression and anxiety
2012 Feb
29
111-22
Rationale for Using Exercise in the Treatment of Stimulant Use Disorders.
Greer TL, Ring KM, Warden D, Grannemann BD, Church TS, Somoza E, Blair SN, Szapocznik J, Stoutenberg M, Rethorst C, Walker R, Morris DW, Kosinski AS, Kyle T, Marcus B, Crowell B, Oden N, Nunes E, Trivedi MH
The journal of global drug policy and practice
2012
Measurement-Based Care in the Treatment of Clinical Depression
D. W. Morris, M. Toups and M. H. Trivedi
Focus
2012
10
428-433
Effects of heart disease on depression treatment: results from the COMED study.
Kerber KB, Wisniewski SR, Luther JF, Leuchter AF, D'Empaire I, Trivedi MH, Rush AJ
General hospital psychiatry
2012 Jan-Feb
34
24-34
Depression treatment in patients with general medical conditions: results from the CO-MED trial.
Morris DW, Budhwar N, Husain M, Wisniewski SR, Kurian BT, Luther JF, Kerber K, Rush AJ, Trivedi MH
Annals of family medicine
2012 Jan-Feb
10
23-33
Rationale and methods for site selection for a trial using a novel intervention to treat stimulant abuse.
Warden D, Trivedi MH, Greer TL, Nunes E, Grannemann BD, Horigian VE, Somoza E, Ring K, Kyle T, Szapocznik J
Contemporary clinical trials
2012 Jan
33
29-37
Assessing anxious features in depressed outpatients.
McClintock SM, Husain MM, Bernstein IH, Wisniewski SR, Trivedi MH, Morris D, Alpert J, Warden D, Luther JF, Kornstein SG, Biggs MM, Fava M, Rush AJ
International journal of methods in psychiatric research
2011 Dec
20
e69-82
Measurement-based care for unipolar depression.
Morris DW, Trivedi MH
Current psychiatry reports
2011 Dec
13
446-58
Using algorithms and computerized decision support systems to treat major depression.
Shelton RC, Trivedi MH
The Journal of clinical psychiatry
2011 Dec
72
12
e36
Moderators of antidepressant response in major depression.
Shelton RC, Trivedi MH
The Journal of clinical psychiatry
2011 Oct
72
10
e32
Effects of race and ethnicity on depression treatment outcomes: the CO-MED trial.
Lesser IM, Zisook S, Gaynes BN, Wisniewski SR, Luther JF, Fava M, Khan A, McGrath P, Warden D, Rush AJ, Trivedi M,
Psychiatric services (Washington, D.C.)
2011 Oct
62
10
1167-79
Changes in depressive symptoms and social functioning in the sequenced treatment alternatives to relieve depression study.
Denninger JW, van Nieuwenhuizen AO, Wisniewski SR, Luther JF, Trivedi MH, Rush AJ, Gollan JK, Pizzagalli DA, Fava M
The Journal of nervous and mental disease
2011 Oct
199
10
807-10
Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
Zisook S, Lesser IM, Lebowitz B, Rush AJ, Kallenberg G, Wisniewski SR, Nierenberg AA, Fava M, Luther JF, Morris DW, Trivedi MH
The Journal of clinical psychiatry
2011 Oct
72
10
1322-32
Power of automated algorithms for combining time-line follow-back and urine drug screening test results in stimulant-abuse clinical trials.
Oden NL, VanVeldhuisen PC, Wakim PG, Trivedi MH, Somoza E, Lewis D
The American journal of drug and alcohol abuse
2011 Sep
37
350-7
Performance improvement CME: algorithms and EMRs in depression.
Shelton RC, Trivedi MH
The Journal of clinical psychiatry
2011 Sep
72
e29
Determining the primary endpoint for a stimulant abuse trial: lessons learned from STRIDE (CTN 0037).
Trivedi MH, Greer TL, Potter JS, Grannemann BD, Nunes EV, Rethorst C, Warden D, Ring KM, Somoza E
The American journal of drug and alcohol abuse
2011 Sep
37
339-49
Factor structure and dimensionality of the two depression scales in STAR*D using level 1 datasets.
Bech P, Fava M, Trivedi MH, Wisniewski SR, Rush AJ
Journal of affective disorders
2011 Aug
132
396-400
Depression outcomes in psychiatric clinical practice: using a self-rated measure of depression severity.
Katzelnick DJ, Duffy FF, Chung H, Regier DA, Rae DS, Trivedi MH
Psychiatric services (Washington, D.C.)
2011 Aug
62
929-35
Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study.
Rush AJ, Trivedi MH, Stewart JW, Nierenberg AA, Fava M, Kurian BT, Warden D, Morris DW, Luther JF, Husain MM, Cook IA, Shelton RC, Lesser IM, Kornstein SG, Wisniewski SR
The American journal of psychiatry
2011 Jul
168
689-701
Using moderator-based algorithms and electronic medical records to achieve optimal outcomes in depression.
Shelton RC, Trivedi MH
The Journal of clinical psychiatry
2011 Jul
72
e24
Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk.
Trivedi MH, Wisniewski SR, Morris DW, Fava M, Gollan JK, Warden D, Nierenberg AA, Gaynes BN, Husain MM, Luther JF, Zisook S, Rush AJ
The Journal of clinical psychiatry
2011 Jun
72
757-64
Effects of serum Brain Derived Neurotrophic Factor on exercise augmentation treatment of depression.
Toups MS, Greer TL, Kurian BT, Grannemann BD, Carmody TJ, Huebinger R, Rethorst C, Trivedi MH
Journal of psychiatric research
2011 Jun
1301-6
Concise associated symptoms tracking scale: a brief self-report and clinician rating of symptoms associated with suicidality.
Trivedi MH, Wisniewski SR, Morris DW, Fava M, Kurian BT, Gollan JK, Nierenberg AA, Warden D, Gaynes BN, Luther JF, A John R
The Journal of clinical psychiatry
2011 Jun
72
765-74
Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child study.
Wickramaratne P, Gameroff MJ, Pilowsky DJ, Hughes CW, Garber J, Malloy E, King C, Cerda G, Sood AB, Alpert JE, Trivedi MH, Fava M, Rush AJ, Wisniewski S, Weissman MM
The American journal of psychiatry
2011 Jun
168
593-602
Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison.
Trivedi MH, Greer TL, Church TS, Carmody TJ, Grannemann BD, Galper DI, Dunn AL, Earnest CP, Sunderajan P, Henley SS, Blair SN
The Journal of clinical psychiatry
2011 May
72
677-84
Prospective trial of equine-assisted activities in autism spectrum disorder.
Kern JK, Fletcher CL, Garver CR, Mehta JA, Grannemann BD, Knox KR, Richardson TA, Trivedi MH
Alternative therapies in health and medicine
2011 May-Jun
17
14-20
Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: A CO-MED report.
Bobo WV, Chen H, Trivedi MH, Stewart JW, Nierenberg AA, Fava M, Kurian BT, Warden D, Morris DW, Luther JF, Husain MM, Cook IA, Lesser IM, Kornstein SG, Wisniewski SR, Rush AJ, Shelton RC
Journal of affective disorders
2011 May
467-76
Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication.
McClintock SM, Husain MM, Wisniewski SR, Nierenberg AA, Stewart JW, Trivedi MH, Cook I, Morris D, Warden D, Rush AJ
Journal of clinical psychopharmacology
2011 Apr
31
180-6
Challenges and algorithm-guided treatment in major depressive disorder.
Shelton RC, Trivedi MH
The Journal of clinical psychiatry
2011 Apr
72
e14
Analysis of suicidality in pooled data from 2 double-blind, placebo-controlled aripiprazole adjunctive therapy trials in major depressive disorder.
Weisler RH, Khan A, Trivedi MH, Yang H, Eudicone JM, Pikalov A, Tran QV, Berman RM, Carlson BX
The Journal of clinical psychiatry
2011 Apr
72
548-55
Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder.
Perlis RH, Uher R, Ostacher M, Goldberg JF, Trivedi MH, Rush AJ, Fava M
Archives of general psychiatry
2011 Apr
68
351-60
Antenatal depression: a rationale for studying exercise.
Shivakumar G, Brandon AR, Snell PG, Santiago-Muñoz P, Johnson NL, Trivedi MH, Freeman MP
Depression and anxiety
2011 Mar
28
234-42
Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study.
Thase ME, Gelenberg A, Kornstein SG, Kocsis JH, Trivedi MH, Ninan P, Li T, Pedersen R, Keller M
Journal of psychiatric research
2011 Mar
45
412-20
Crisis of confidence: antidepressant risk versus benefit.
Nierenberg AA, Leon AC, Price LH, Shelton RC, Trivedi MH
The Journal of clinical psychiatry
2011 Mar
72
e11
Fractional anisotropy changes after several weeks of daily left high-frequency repetitive transcranial magnetic stimulation of the prefrontal cortex to treat major depression.
Kozel FA, Johnson KA, Nahas Z, Nakonezny PA, Morgan PS, Anderson BS, Kose S, Li X, Lim KO, Trivedi MH, George MS
The journal of ECT
2011 Mar
27
5-10
The relationship between adverse events during selective serotonin reuptake inhibitor treatment for major depressive disorder and nonremission in the suicide assessment methodology study.
Daly EJ, Trivedi MH, Fava M, Shelton R, Wisniewski SR, Morris DW, Stegman D, Preskorn SH, Rush AJ
Journal of clinical psychopharmacology
2011 Feb
31
31-8
The current crisis of confidence in antidepressants.
Nierenberg AA, Leon AC, Price LH, Shelton RC, Trivedi MH
The Journal of clinical psychiatry
2011 Jan
72
27-33
Stimulant reduction intervention using dosed exercise (STRIDE) - CTN 0037: study protocol for a randomized controlled trial.
Trivedi MH, Greer TL, Grannemann BD, Church TS, Somoza E, Blair SN, Szapocznik J, Stoutenberg M, Rethorst C, Warden D, Ring KM, Walker R, Morris DW, Kosinski AS, Kyle T, Marcus B, Crowell B, Oden N, Nunes E
Trials
2011
12
206
Measurement-based care in psychiatric practice: a policy framework for implementation.
Harding KJ, Rush AJ, Arbuckle M, Trivedi MH, Pincus HA
The Journal of clinical psychiatry
2011 Jan
1136-43
Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder.
Dunlop BW, Li T, Kornstein SG, Friedman ES, Rothschild AJ, Pedersen R, Ninan P, Keller M, Trivedi MH
Journal of psychiatric research
2011 Jan
45
96-103
Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder.
Berman RM, Thase ME, Trivedi MH, Hazel JA, Marler SV, McQuade RD, Carson W, Baker RA, Marcus RN
Neuropsychiatric disease and treatment
2011
303-12
Remission with venlafaxine extended release or selective serotonin reuptake inhibitors in depressed patients: a randomized, open-label study.
Thase ME, Ninan PT, Musgnung JJ, Trivedi MH
The primary care companion to CNS disorders
2011
13
Functional connectivity of brain structures correlates with treatment outcome in major depressive disorder.
Kozel FA, Rao U, Lu H, Nakonezny PA, Grannemann B, McGregor T, Croarkin PE, Mapes KS, Tamminga CA, Trivedi MH
Frontiers in psychiatry / Frontiers Research Foundation
2011
Psychometric properties of the Quick Inventory of Depressive Symptomatology in adolescents.
Bernstein IH, Rush AJ, Trivedi MH, Hughes CW, Macleod L, Witte BP, Jain S, Mayes TL, Emslie GJ
International journal of methods in psychiatric research
2010 Dec
19
185-94
Psychometric evaluation of the Snaith-Hamilton pleasure scale in adult outpatients with major depressive disorder.
Nakonezny PA, Carmody TJ, Morris DW, Kurian BT, Trivedi MH
International clinical psychopharmacology
2010 Nov
25
328-33
Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release.
Trivedi MH, Dunner DL, Kornstein SG, Thase ME, Zajecka JM, Rothschild AJ, Friedman ES, Shelton RC, Keller MB, Kocsis JH, Gelenberg A
Journal of affective disorders
2010 Nov
126
420-9
Depressive symptoms and metabolic syndrome in preventive healthcare: the Cooper Center longitudinal study.
East C, Willis BL, Barlow CE, Grannemann BD, FitzGerald SJ, DeFina LF, Trivedi MH
Metabolic syndrome and related disorders
2010 Oct
451-7
Diagnostic utility of the Quick Inventory of Depressive Symptomatology (QIDS-C16 and QIDS-SR16) in the elderly.
Doraiswamy PM, Bernstein IH, Rush AJ, Kyutoku Y, Carmody TJ, Macleod L, Venkatraman S, Burks M, Stegman D, Witte B, Trivedi MH
Acta psychiatrica Scandinavica
2010 Sep
122
226-34
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report.
Meyer RE, Salzman C, Youngstrom EA, Clayton PJ, Goodwin FK, Mann JJ, Alphs LD, Broich K, Goodman WK, Greden JF, Meltzer HY, Normand SL, Posner K, Shaffer D, Oquendo MA, Stanley B, Trivedi MH, Turecki G, Beasley CM, Beautrais AL, Bridge JA, Brown GK, Revicki DA, Ryan ND, Sheehan DV
The Journal of clinical psychiatry
2010 Aug
71
1040-6
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement.
Meyer RE, Salzman C, Youngstrom EA, Clayton PJ, Goodwin FK, Mann JJ, Alphs LD, Broich K, Goodman WK, Greden JF, Meltzer HY, Normand SL, Posner K, Shaffer D, Oquendo MA, Stanley B, Trivedi MH, Turecki G, Beasley CM, Beautrais AL, Bridge JA, Brown GK, Revicki DA, Ryan ND, Sheehan DV
The Journal of clinical psychiatry
2010 Aug
71
e1-e21
A Comparison of the QIDS-C16, QIDS-SR16, and the MADRS in an Adult Outpatient Clinical Sample.
Bernstein IH, Rush AJ, Stegman D, Macleod L, Witte B, Trivedi MH
CNS spectrums
2010 Jul
15
458-68
The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in women.
Kornstein SG, Young EA, Harvey AT, Wisniewski SR, Barkin JL, Thase ME, Trivedi MH, Nierenberg AA, Rush AJ
Menopause (New York, N.Y.)
2010 Jul
17
828-39
Anticipated Benefits of Care (ABC): psychometrics and predictive value in psychiatric disorders.
Warden D, Trivedi MH, Carmody TJ, Gollan JK, Kashner TM, Lind L, Crismon ML, Rush AJ
Psychological medicine
2010 Jun
40
955-65
Complementary and alternative medicine in major depressive disorder: the American Psychiatric Association Task Force report.
Freeman MP, Fava M, Lake J, Trivedi MH, Wisner KL, Mischoulon D
The Journal of clinical psychiatry
2010 Jun
71
669-81
Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report.
Warden D, Trivedi MH, Wisniewski SR, Kurian B, Zisook S, Kornstein SG, Friedman ES, Miyahara S, Leuchter AF, Fava M, Rush AJ
Journal of clinical psychopharmacology
2010 Jun
30
259-66
Insomnia in patients with depression: a STAR*D report.
Sunderajan P, Gaynes BN, Wisniewski SR, Miyahara S, Fava M, Akingbala F, DeVeaugh-Geiss J, Rush AJ, Trivedi MH
CNS spectrums
2010 Jun
15
394-404
Indicators of pretreatment suicidal ideation in adults with major depressive disorder.
Morris DW, Trivedi MH, Husain MM, Fava M, Budhwar N, Wisniewski SR, Miyahara S, Gollan JK, Davis LL, Daly EJ, Rush AJ
Acta psychiatrica Scandinavica
2010 Jun
121
480-4
Agomelatine in the treatment of major depressive disorder: an 8-week, multicenter, randomized, placebo-controlled trial.
Stahl SM, Fava M, Trivedi MH, Caputo A, Shah A, Post A
The Journal of clinical psychiatry
2010 May
71
616-26
Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death.
Hedayati SS, Minhajuddin AT, Afshar M, Toto RD, Trivedi MH, Rush AJ
JAMA : the journal of the American Medical Association
2010 May
303
19
1946-53
Effect of 11 September 2001 terrorist attacks in the USA on suicide in areas surrounding the crash sites.
Claassen CA, Carmody T, Stewart SM, Bossarte RM, Larkin GL, Woodward WA, Trivedi MH
The British journal of psychiatry : the journal of mental science
2010 May
196
359-64
Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response.
Binder EB, Owens MJ, Liu W, Deveau TC, Rush AJ, Trivedi MH, Fava M, Bradley B, Ressler KJ, Nemeroff CB
Archives of general psychiatry
2010 Apr
67
369-79
Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies.
Tohen M, Case M, Trivedi MH, Thase ME, Burke SJ, Durell TM
The Journal of clinical psychiatry
2010 Apr
71
451-62
Defining and measuring functional recovery from depression.
Greer TL, Kurian BT, Trivedi MH
CNS drugs
2010 Apr
24
267-84
Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes.
Davis LL, Wisniewski SR, Howland RH, Trivedi MH, Husain MM, Fava M, McGrath PJ, Balasubramani GK, Warden D, Rush AJ
Drug and alcohol dependence
2010 Mar
107
2-3
161-70
Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depression.
Denton WH, Carmody TJ, Rush AJ, Thase ME, Trivedi MH, Arnow BA, Klein DN, Keller MB
Psychological medicine
2010 Mar
40
415-24
Health-related quality of life in depression: a STAR*D report.
Daly EJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Gaynes BN, Warden D, Morris DW, Luther JF, Farabaugh A, Cook I, Rush AJ
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists
2010 Feb
22
43-55
Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report.
Leuchter AF, Husain MM, Cook IA, Trivedi MH, Wisniewski SR, Gilmer WS, Luther JF, Fava M, Rush AJ
Psychological medicine
2010 Feb
40
239-51
Do atypical features affect outcome in depressed outpatients treated with citalopram?
Stewart JW, McGrath PJ, Fava M, Wisniewski SR, Zisook S, Cook I, Nierenberg AA, Trivedi MH, Balasubramani GK, Warden D, Lesser I, John Rush A
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)
2010 Feb
13
15-30
Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.
Nierenberg AA, Husain MM, Trivedi MH, Fava M, Warden D, Wisniewski SR, Miyahara S, Rush AJ
Psychological medicine
2010 Jan
40
41-50
The impact of diabetes on depression treatment outcomes.
Bryan C, Songer T, Brooks MM, Rush AJ, Thase ME, Gaynes B, Balasubramani GK, Trivedi MH, Fava M, Wisniewski SR
General hospital psychiatry
2010 Jan-Feb
32
33-41
Exercise in the treatment of depression.
Greer TL, Trivedi MH
Current psychiatry reports
2009 Dec
11
466-72
DATE: Depressed adolescents treated with exercise: Study rationale and design for a pilot study.
Hughes CW, Trivedi MH, Cleaver J, Greer TL, Emslie GJ, Kennard B, Dorman S, Bain T, Dubreuil J, Barnes C
Mental health and physical activity
2009 Dec
76-85
What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression.
Gaynes BN, Warden D, Trivedi MH, Wisniewski SR, Fava M, Rush AJ
Psychiatric services (Washington, D.C.)
2009 Nov
60
11
1439-45
Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial.
Kocsis JH, Gelenberg AJ, Rothbaum BO, Klein DN, Trivedi MH, Manber R, Keller MB, Leon AC, Wisniewski SR, Arnow BA, Markowitz JC, Thase ME
Archives of general psychiatry
2009 Nov
66
11
1178-88
Release bias in accessing medical records in clinical trials: a STAR*D report.
Kashner TM, Trivedi MH, Wicker A, Fava M, Shores-Wilson K, Wisniewski SR, Rush AJ
International journal of methods in psychiatric research
2009 Sep
18
147-58
Treating partial responders to antidepressant treatment.
Trivedi MH
The Journal of clinical psychiatry
2009 Sep
70
e31
Factors associated with concomitant psychotropic drug use in the treatment of major depression: a STAR*D Report.
Shelton RC, Hollon SD, Wisniewski SR, Alpert JE, Balasubramani GK, Friedman ES, Rush AJ, Trivedi MH, Preskorn SH
CNS spectrums
2009 Sep
14
487-98
Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study.
Leuchter AF, Cook IA, Marangell LB, Gilmer WS, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, McCracken JT, Fava M, Iosifescu D, Greenwald S
Psychiatry research
2009 Sep
169
124-31
Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study.
Zisook S, Trivedi MH, Warden D, Lebowitz B, Thase ME, Stewart JW, Moutier C, Fava M, Wisniewski SR, Luther J, Rush AJ
Journal of affective disorders
2009 Sep
117
1-2
63-73
Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.
Leuchter AF, Cook IA, Gilmer WS, Marangell LB, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, Fava M, Iosifescu D, Greenwald S
Psychiatry research
2009 Sep
169
132-8
STAR*D: revising conventional wisdom.
Rush AJ, Warden D, Wisniewski SR, Fava M, Trivedi MH, Gaynes BN, Nierenberg AA
CNS drugs
2009 Aug
23
627-47
Strategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms.
Kurian BT, Greer TL, Trivedi MH
Expert review of neurotherapeutics
2009 Jul
975-84
A psychometric evaluation of the clinician-rated Quick Inventory of Depressive Symptomatology (QIDS-C16) in patients with bipolar disorder.
Bernstein IH, Rush AJ, Suppes T, Trivedi MH, Woo A, Kyutoku Y, Crismon ML, Dennehy E, Carmody TJ
International journal of methods in psychiatric research
2009 Jun
18
138-46
What predicts attrition in second step medication treatments for depression?: a STAR*D Report.
Warden D, Rush AJ, Wisniewski SR, Lesser IM, Kornstein SG, Balasubramani GK, Thase ME, Preskorn SH, Nierenberg AA, Young EA, Shores-Wilson K, Trivedi MH
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)
2009 May
12
459-73
Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder.
Perlis RH, Fijal B, Adams DH, Sutton VK, Trivedi MH, Houston JP
Biological psychiatry
2009 May
65
785-91
Remission, response without remission, and nonresponse in major depressive disorder: impact on functioning.
Trivedi MH, Corey-Lisle PK, Guo Z, Lennox RD, Pikalov A, Kim E
International clinical psychopharmacology
2009 May
24
133-8
Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report.
Wisniewski SR, Rush AJ, Nierenberg AA, Gaynes BN, Warden D, Luther JF, McGrath PJ, Lavori PW, Thase ME, Fava M, Trivedi MH
The American journal of psychiatry
2009 May
166
599-607
Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorder.
Perlis RH, Fava M, Trivedi MH, Alpert J, Luther JF, Wisniewski SR, Rush AJ
Acta psychiatrica Scandinavica
2009 Apr
119
282-9
Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.
Berman RM, Fava M, Thase ME, Trivedi MH, Swanink R, McQuade RD, Carson WH, Adson D, Taylor L, Hazel J, Marcus RN
CNS spectrums
2009 Apr
14
197-206
Voice response system to measure healthcare costs: a STAR*D report.
Kashner TM, Trivedi MH, Wicker A, Fava M, Greist JH, Mundt JC, Shores-Wilson K, Rush AJ, Wisniewski SR
The American journal of managed care
2009 Mar
15
153-62
Predictors of attrition during one year of depression treatment: a roadmap to personalized intervention.
Warden D, Rush AJ, Carmody TJ, Kashner TM, Biggs MM, Crismon ML, Trivedi MH
Journal of psychiatric practice
2009 Mar
15
113-24
An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
Trivedi MH, Thase ME, Osuntokun O, Henley DB, Case M, Watson SB, Campbell GM, Corya SA
The Journal of clinical psychiatry
2009 Mar
70
387-96
Abnormal brain response to cholinergic challenge in chronic encephalopathy from the 1991 Gulf War.
Haley RW, Spence JS, Carmack PS, Gunst RF, Schucany WR, Petty F, Devous MD, Bonte FJ, Trivedi MH
Psychiatry research
2009 Mar
171
207-20
Family history of depression and therapeutic outcome: findings from STAR*D.
Husain MM, Rush AJ, Wisniewski SR, McClintock SM, Fava M, Nierenberg AA, Davis L, Balasubramani GK, Young E, Albala AA, Trivedi MH
The Journal of clinical psychiatry
2009 Feb
70
185-95
Sex differences in response to citalopram: a STAR*D report.
Young EA, Kornstein SG, Marcus SM, Harvey AT, Warden D, Wisniewski SR, Balasubramani GK, Fava M, Trivedi MH, John Rush A
Journal of psychiatric research
2009 Feb
43
503-11
Barriers to implementation of a computerized decision support system for depression: an observational report on lessons learned in "real world" clinical settings.
Trivedi MH, Daly EJ, Kern JK, Grannemann BD, Sunderajan P, Claassen CA
BMC medical informatics and decision making
2009
Do Depressed Patients With Diabetes Experience More Side Effects When Treated With CitalopramThan Their Counterparts Without Diabetes? A STAR*D Study.
Bryan C, Songer T, Brooks MM, Thase ME, Gaynes B, Klinkman M, Balasubramani GK, Rush AJ, Trivedi MH, Fava M, Wisniewski SR
Primary care companion to the Journal of clinical psychiatry
2009
11
186-196
Early adversity in chronic depression: clinical correlates and response to pharmacotherapy.
Klein DN, Arnow BA, Barkin JL, Dowling F, Kocsis JH, Leon AC, Manber R, Rothbaum BO, Trivedi MH, Wisniewski SR
Depression and anxiety
2009
26
701-10
A computerized decision support system for depression in primary care.
Kurian BT, Trivedi MH, Grannemann BD, Claassen CA, Daly EJ, Sunderajan P
Primary care companion to the Journal of clinical psychiatry
2009
11
140-6
Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
Howland RH, Rush AJ, Wisniewski SR, Trivedi MH, Warden D, Fava M, Davis LL, Balasubramani GK, McGrath PJ, Berman SR
Drug and alcohol dependence
2009 Jan
99
1-3
248-60
Diurnal mood variation in outpatients with major depressive disorder.
Morris DW, Trivedi MH, Fava M, Wisniewski SR, Balasubramani GK, Khan AY, Jain S, Rush AJ
Depression and anxiety
2009
26
851-63
Effectiveness study of venlafaxine-XR combined with aripiprazole for chronic or recurrent major depressive disorder
A. A. Nierenberg, M. H. Trivedi, B. N. Gaynes, J. Mitchell, L. L. Davis, M. M. Husain, et al.
Australian and New Zealand Journal of Psychiatry
2009
43
10
956-967
Treating depression to full remission.
Trivedi MH
The Journal of clinical psychiatry
2009 Jan
70
e01
Identifying risk for attrition during treatment for depression.
Warden D, Trivedi MH, Wisniewski SR, Lesser IM, Mitchell J, Balasubramani GK, Fava M, Shores-Wilson K, Stegman D, Rush AJ
Psychotherapy and psychosomatics
2009
78
372-9
Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial.
Friedman ES, Wisniewski SR, Gilmer W, Nierenberg AA, Rush AJ, Fava M, Zisook S, Balasubramani GK, Trivedi MH
Depression and anxiety
2009
26
612-21
The impact of nonclinical factors on care use for patients with depression: a STAR*D report.
Kashner TM, Trivedi MH, Wicker A, Fava M, Wisniewski SR, Rush AJ
CNS neuroscience & therapeutics
2009
15
320-32
Tools and strategies for ongoing assessment of depression: a measurement-based approach to remission.
Trivedi MH
The Journal of clinical psychiatry
2009
70 Suppl 6
26-31
Telephone-based assessments to minimize missing data in longitudinal depression trials: a project IMPACTS study report.
Claassen C, Kurian B, Trivedi MH, Grannemann BD, Tuli E, Pipes R, Preston AM, Flood A
Contemporary clinical trials
2009 Jan
30
13-9
Safety and Tolerability of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Post Hoc Analysis (studies CN138-139 and CN138-163).
Nelson JC, Thase ME, Trivedi MH, Fava M, Han J, Van Tran Q, Pikalov A, Qi Y, Carlson BX, Marcus RN, Berman RM
Primary care companion to the Journal of clinical psychiatry
2009
11
344-352
Assessing Rates and Predictors of Tachyphylaxis During the Prevention of Recurrent Episodes of Depression With Venlafaxine ER for Two Years (PREVENT) Study.
Rothschild AJ, Dunlop BW, Dunner DL, Friedman ES, Gelenberg A, Holland P, Kocsis JH, Kornstein SG, Shelton R, Trivedi MH, Zajecka JM, Goldstein C, Thase ME, Pedersen R, Keller MB
Psychopharmacology bulletin
2009
42
5-20
Income and attrition in the treatment of depression: a STAR*D report.
Warden D, Rush AJ, Wisniewski SR, Lesser IM, Thase ME, Balasubramani GK, Shores-Wilson K, Nierenberg AA, Trivedi MH
Depression and anxiety
2009
26
622-33
Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
Trivedi MH, Thase ME, Fava M, Nelson CJ, Yang H, Qi Y, Tran QV, Pikalov A, Carlson BX, Marcus RN, Berman RM
The Journal of clinical psychiatry
2008 Dec
69
12
1928-36
Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report.
McGrath PJ, Khan AY, Trivedi MH, Stewart JW, Morris DW, Wisniewski SR, Miyahara S, Nierenberg AA, Fava M, Rush JA
The Journal of clinical psychiatry
2008 Dec
69
12
1847-55
Do geographic regions with higher suicide rates also have higher rates of nonfatal intentional self-harm?
Claassen CA, Carmody T, Bossarte R, Trivedi MH, Elliott S, Currier GW
Suicide & life-threatening behavior
2008 Dec
38
637-49
Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study.
Perlis RH, Moorjani P, Fagerness J, Purcell S, Trivedi MH, Fava M, Rush AJ, Smoller JW
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
2008 Nov
33
12
2810-9
Remission of maternal depression: relations to family functioning and youth internalizing and externalizing symptoms.
Foster CE, Webster MC, Weissman MM, Pilowsky DJ, Wickramaratne PJ, Talati A, Rush AJ, Hughes CW, Garber J, Malloy E, Cerda G, Kornstein SG, Alpert JE, Wisniewski SR, Trivedi MH, Fava M, King CA
Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53
2008 Oct
37
714-24
The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies.
Gelenberg AJ, Thase ME, Meyer RE, Goodwin FK, Katz MM, Kraemer HC, Potter WZ, Shelton RC, Fava M, Khan A, Trivedi MH, Ninan PT, Mann JJ, Bergeson S, Endicott J, Kocsis JH, Leon AC, Manji HK, Rosenbaum JF
The Journal of clinical psychiatry
2008 Oct
69
10
1513-28
Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression.
Howland RH, Wilson MG, Kornstein SG, Clayton AH, Trivedi MH, Wohlreich MM, Fava M
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists
2008 Oct-Dec
20
209-18
The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.
Arnold LM, Meyers AL, Sunderajan P, Montano CB, Kass E, Trivedi M, Wohlreich MM
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists
2008 Oct-Dec
20
187-93
An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder.
Leuchter AF, Lesser IM, Trivedi MH, Rush AJ, Morris DW, Warden D, Fava M, Wisniewski SR, Luther JF, Perales M, Gaynes BN, Stewart JW
Journal of psychiatric practice
2008 Sep
14
271-80
Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatment.
Kocsis JH, Gelenberg AJ, Rothbaum B, Klein DN, Trivedi MH, Manber R, Keller MB, Howland R, Thase ME
Journal of affective disorders
2008 Sep
110
1-2
55-61
Course and Severity of Maternal Depression: Associations with Family Functioning and Child Adjustment.
Foster CE, Webster MC, Weissman MM, Pilowsky DJ, Wickramaratne PJ, Rush AJ, Hughes CW, Garber J, Malloy E, Cerda G, Kornstein SG, Alpert JE, Wisniewski SR, Trivedi MH, Fava M, King CA
Journal of youth and adolescence
2008 Sep
37
906-916
Children of depressed mothers 1 year after the initiation of maternal treatment: findings from the STAR*D-Child Study.
Pilowsky DJ, Wickramaratne P, Talati A, Tang M, Hughes CW, Garber J, Malloy E, King C, Cerda G, Sood AB, Alpert JE, Trivedi MH, Fava M, Rush AJ, Wisniewski S, Weissman MM
The American journal of psychiatry
2008 Sep
165
1136-47
Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report.
Gilmer WS, Gollan JK, Wisniewski SR, Howland RH, Trivedi MH, Miyahara S, Fleck J, Thase ME, Alpert JE, Nierenberg AA, Warden D, Fava M, Rush AJ
The Journal of clinical psychiatry
2008 Aug
69
1246-56
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
Rush AJ, Wisniewski SR, Warden D, Luther JF, Davis LL, Fava M, Nierenberg AA, Trivedi MH
Archives of general psychiatry
2008 Aug
65
870-80
Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone.
Manber R, Kraemer HC, Arnow BA, Trivedi MH, Rush AJ, Thase ME, Rothbaum BO, Klein DN, Kocsis JH, Gelenberg AJ, Keller ME
Journal of consulting and clinical psychology
2008 Jun
76
459-67
Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
Pollack MH, Tiller J, Xie F, Trivedi MH
Journal of clinical psychopharmacology
2008 Jun
28
308-16
Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine.
Trivedi MH, Desaiah D, Ossanna MJ, Pritchett YL, Brannan SK, Detke MJ
International clinical psychopharmacology
2008 May
23
161-9
Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D.
Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Balasubramani GK, McGrath PJ, Thase ME, Klinkman M, Nierenberg AA, Yates WR, Fava M
Journal of general internal medicine
2008 May
23
551-60
Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study.
Marcus SM, Kerber KB, Rush AJ, Wisniewski SR, Nierenberg A, Balasubramani GK, Ritz L, Kornstein S, Young EA, Trivedi MH
Comprehensive psychiatry
2008 May-Jun
49
238-46
A comparison of baseline sociodemographic and clinical characteristics between major depressive disorder patients with and without diabetes: a STAR*D report.
Bryan CJ, Songer TJ, Brooks MM, Thase ME, Gaynes BN, Klinkman M, Rush AJ, Trivedi MH, Fava M, Wisniewski SR
Journal of affective disorders
2008 May
108
1-2
113-20
Family history of completed suicide and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study.
Nierenberg AA, Alpert JE, Gaynes BN, Warden D, Wisniewski SR, Biggs MM, Trivedi MH, Barkin JL, Rush AJ
Journal of affective disorders
2008 May
108
1-2
129-34
Folate and unipolar depression.
Morris DW, Trivedi MH, Rush AJ
Journal of alternative and complementary medicine (New York, N.Y.)
2008 Apr
14
277-85
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Marcus RN, McQuade RD, Carson WH, Hennicken D, Fava M, Simon JS, Trivedi MH, Thase ME, Berman RM
Journal of clinical psychopharmacology
2008 Apr
28
156-65
Prenatal depression in women hospitalized for obstetric risk.
Brandon AR, Trivedi MH, Hynan LS, Miltenberger PD, Labat DB, Rifkin JB, Stringer CA
The Journal of clinical psychiatry
2008 Apr
69
635-43
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.
Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, Biggs MM, Zisook S, Leuchter A, Howland R, Warden D, Trivedi MH
The American journal of psychiatry
2008 Mar
165
342-51
Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression.
Trivedi MH, Hollander E, Nutt D, Blier P
The Journal of clinical psychiatry
2008 Feb
69
246-58
Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: a meta-analysis of individual patient data from 10 double-blind, randomized clinical trials.
Papakostas GI, Trivedi MH, Alpert JE, Seifert CA, Krishen A, Goodale EP, Tucker VL
Journal of psychiatric research
2008 Jan
42
134-40
Symptom features of postpartum depression: are they distinct?
Bernstein IH, Rush AJ, Yonkers K, Carmody TJ, Woo A, McConnell K, Trivedi MH
Depression and anxiety
2008
25
20-6
Treatment strategies to improve and sustain remission in major depressive disorder.
Trivedi MH, Daly EJ
Dialogues in clinical neuroscience
2008
10
377-84
Examining the efficacy of adjunctive aripiprazole in major depressive disorder: a pooled analysis of 2 studies.
Thase ME, Trivedi MH, Nelson JC, Fava M, Swanink R, Tran QV, Pikalov A, Yang H, Carlson BX, Marcus RN, Berman RM
Primary care companion to the Journal of clinical psychiatry
2008
10
440-7
Treatment outcomes for older depressed patients with earlier versus late onset of first depressive episode: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.
Kozel FA, Trivedi MH, Wisniewski SR, Miyahara S, Husain MM, Fava M, Lebowitz B, Zisook S, Rush AJ
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
2008 Jan
16
58-64
The STAR*D study: treating depression in the real world.
Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Spencer D, Fava M
Cleveland Clinic journal of medicine
2008 Jan
75
57-66
Developing a neuropsychiatric functional brain imaging test.
Kozel FA, Trivedi MH
Neurocase
2008
14
54-8
REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: rationale and design.
Trivedi MH, Kocsis JH, Thase ME, Morris DW, Wisniewski SR, Leon AC, Gelenberg AJ, Klein DN, Niederehe G, Schatzberg AF, Ninan PT, Keller MB
Psychopharmacology bulletin
2008
41
5-33
Systematic Use of Patient-Rated Depression Severity Monitoring: Is It Helpful and Feasible in Clinical Psychiatry?
H. C. Duffy FF, M.D. Madhukar Trivedi, M.D. Donald S. Rae, M.S. Darrel A. Regier, M.D., M.P.H. David J. Katzelnick, M.D.
Psychiatric Services
2008
59
10
1148-1154
Remission of maternal depression and child symptoms among single mothers: a STAR*D-Child report.
Talati A, Wickramaratne PJ, Pilowsky DJ, Alpert JE, Cerda G, Garber J, Hughes CW, King CA, Malloy E, Sood AB, Verdeli H, Trivedi MH, Rush AJ, Weissman MM
Social psychiatry and psychiatric epidemiology
2007 Dec
42
12
962-71
A review of quetiapine in combination with antidepressant therapy in patients with depression.
Daly EJ, Trivedi MH
Neuropsychiatric disease and treatment
2007 Dec
855-67
Are depressed outpatients with and without a family history of substance use disorder different? A baseline analysis of the STAR*D cohort.
Davis LL, Frazier EC, Gaynes BN, Trivedi MH, Wisniewski SR, Fava M, Barkin J, Kashner TM, Shelton RC, Alpert JE, Rush AJ
The Journal of clinical psychiatry
2007 Dec
68
12
1931-8
The STAR*D Project results: a comprehensive review of findings.
Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR
Current psychiatry reports
2007 Dec
449-59
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.
Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Dunlop BW, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen R, Yan B, Ahmed S, Schmidt M, Ninan PT
Biological psychiatry
2007 Dec
62
12
1371-9
Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care.
Trivedi MH, Rush AJ, Gaynes BN, Stewart JW, Wisniewski SR, Warden D, Ritz L, Luther JF, Stegman D, Deveaugh-Geiss J, Howland R
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
2007 Dec
32
12
2479-89
Ethnicity/race and outcome in the treatment of depression: results from STAR*D.
Lesser IM, Castro DB, Gaynes BN, Gonzalez J, Rush AJ, Alpert JE, Trivedi M, Luther JF, Wisniewski SR,
Medical care
2007 Nov
45
11
1043-51
Electronic source materials in clinical research: acceptability and validity of symptom self-rating in major depressive disorder.
Cook IA, Balasubramani GK, Eng H, Friedman E, Young EA, Martin J, Nay WT, Ritz L, Rush AJ, Stegman D, Warden D, Trivedi MH, Wisniewski SR
Journal of psychiatric research
2007 Nov
41
737-43
Effect of age at onset on the course of major depressive disorder.
Zisook S, Lesser I, Stewart JW, Wisniewski SR, Balasubramani GK, Fava M, Gilmer WS, Dresselhaus TR, Thase ME, Nierenberg AA, Trivedi MH, Rush AJ
The American journal of psychiatry
2007 Oct
164
10
1539-46
Diurnal mood variation in outpatients with major depressive disorder: implications for DSM-V from an analysis of the Sequenced Treatment Alternatives to Relieve Depression Study data.
Morris DW, Rush AJ, Jain S, Fava M, Wisniewski SR, Balasubramani GK, Khan AY, Trivedi MH
The Journal of clinical psychiatry
2007 Sep
68
1339-47
A psychometric evaluation of the CDRS and MADRS in assessing depressive symptoms in children.
Jain S, Carmody TJ, Trivedi MH, Hughes C, Bernstein IH, Morris DW, Emslie GJ, Rush AJ
Journal of the American Academy of Child and Adolescent Psychiatry
2007 Sep
46
1204-12
A pilot study of an electronic, adolescent version of the quick inventory of depressive symptomatology.
Moore HK, Hughes CW, Mundt JC, Rush AJ, Macleod L, Emslie GJ, Jain S, Geralts DS, Bernstein IH, Horrigan JP, Trivedi MH, Greist JH
The Journal of clinical psychiatry
2007 Sep
68
1436-40
Major depressive disorder and comorbid cardiac disease: is there a depressive subtype with greater cardiovascular morbidity? Results from the STAR*D study.
Fraguas R, Iosifescu DV, Alpert J, Wisniewski SR, Barkin JL, Trivedi MH, Rush AJ, Fava M
Psychosomatics
2007 Sep-Oct
48
418-25
Pain in depression: STAR*D study findings.
Husain MM, Rush AJ, Trivedi MH, McClintock SM, Wisniewski SR, Davis L, Luther JF, Zisook S, Fava M
Journal of psychosomatic research
2007 Aug
63
113-22
Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression.
Trivedi MH, Lin EH, Katon WJ
CNS spectrums
2007 Aug
12
8 Suppl 13
1-27
Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression.
Young EA, Kornstein SG, Harvey AT, Wisniewski SR, Barkin J, Fava M, Trivedi MH, Rush AJ
Psychoneuroendocrinology
2007 Aug
32
843-53
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen RD, Yan B, Ahmed S, Musgnung J, Ninan PT
The Journal of clinical psychiatry
2007 Aug
68
1246-56
Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report.
Warden D, Trivedi MH, Wisniewski SR, Davis L, Nierenberg AA, Gaynes BN, Zisook S, Hollon SD, Balasubramani GK, Howland R, Fava M, Stewart JW, Rush AJ
The American journal of psychiatry
2007 Aug
164
1189-97
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study.
Kocsis JH, Thase ME, Trivedi MH, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen RD, Yan B, Ahmed S, Musgnung J, Ninan PT, Keller MB
The Journal of clinical psychiatry
2007 Jul
68
1014-23
Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
Hu XZ, Rush AJ, Charney D, Wilson AF, Sorant AJ, Papanicolaou GJ, Fava M, Trivedi MH, Wisniewski SR, Laje G, Paddock S, McMahon FJ, Manji H, Lipsky RH
Archives of general psychiatry
2007 Jul
64
783-92
Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder.
Hughes CW, Emslie GJ, Crismon ML, Posner K, Birmaher B, Ryan N, Jensen P, Curry J, Vitiello B, Lopez M, Shon SP, Pliszka SR, Trivedi MH
Journal of the American Academy of Child and Adolescent Psychiatry
2007 Jun
46
667-86
Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.
Perlis RH, Purcell S, Fava M, Fagerness J, Rush AJ, Trivedi MH, Smoller JW
Archives of general psychiatry
2007 Jun
64
689-97
Acceptability of second-step treatments to depressed outpatients: a STAR*D report.
Wisniewski SR, Fava M, Trivedi MH, Thase ME, Warden D, Niederehe G, Friedman ES, Biggs MM, Sackeim HA, Shores-Wilson K, McGrath PJ, Lavori PW, Miyahara S, Rush AJ
The American journal of psychiatry
2007 May
164
753-60
Exercise for mood and anxiety disorders.
Otto MW, Church TS, Craft LL, Greer TL, Smits JA, Trivedi MH
The Journal of clinical psychiatry
2007 May
68
669-76
Amelioration by black tea of sodium fluoride-induced changes in protein content of cerebral hemisphere, cerebellum and medulla oblongata in brain region of mice.
Trivedi MH, Verma RJ, Chinoy NJ
Acta poloniae pharmaceutica
2007 May-Jun
64
221-5
Measurement-based care for refractory depression: a clinical decision support model for clinical research and practice.
Trivedi MH, Daly EJ
Drug and alcohol dependence
2007 May
88 Suppl 2
S61-71
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.
Thase ME, Friedman ES, Biggs MM, Wisniewski SR, Trivedi MH, Luther JF, Fava M, Nierenberg AA, McGrath PJ, Warden D, Niederehe G, Hollon SD, Rush AJ
The American journal of psychiatry
2007 May
164
739-52
Clinical vs. self-report versions of the quick inventory of depressive symptomatology in a public sector sample.
Bernstein IH, Rush AJ, Carmody TJ, Woo A, Trivedi MH
Journal of psychiatric research
2007 Apr-Jun
41
3-4
239-46
Sulfhydryl-reactive metals in autism.
Kern JK, Grannemann BD, Trivedi MH, Adams JB
Journal of toxicology and environmental health. Part A
2007 Apr
70
715-21
Family history of mood disorder and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study.
Nierenberg AA, Trivedi MH, Fava M, Biggs MM, Shores-Wilson K, Wisniewski SR, Balasubramani GK, Rush AJ
Journal of psychiatric research
2007 Apr-Jun
41
3-4
214-21
Insured and non-insured depressed outpatients: how do they compare?
Lesser IM, Leuchter AF, Trivedi MH, Davis LL, Wisniewski SR, Balasubramani GK, Fava M, Rush AJ
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists
2007 Apr-Jun
19
73-82
Preadult onset vs. adult onset of major depressive disorder: a replication study.
Zisook S, Rush AJ, Lesser I, Wisniewski SR, Trivedi M, Husain MM, Balasubramani GK, Alpert JE, Fava M
Acta psychiatrica Scandinavica
2007 Mar
115
196-205
Major depression symptoms in primary care and psychiatric care settings: a cross-sectional analysis.
Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Balasubramani GK, Spencer DC, Petersen T, Klinkman M, Warden D, Nicholas L, Fava M
Annals of family medicine
2007 Mar-Apr
126-34
Sensory correlations in autism.
Kern JK, Trivedi MH, Grannemann BD, Garver CR, Johnson DG, Andrews AA, Savla JS, Mehta JA, Schroeder JL
Autism : the international journal of research and practice
2007 Mar
11
123-34
Comparison of quality of life measures in a depressed population.
Wisniewski SR, Rush AJ, Bryan C, Shelton R, Trivedi MH, Marcus S, Husain MM, Hollon SD, Fava M
The Journal of nervous and mental disease
2007 Mar
195
219-25
Assessing physicians' use of treatment algorithms: Project IMPACTS study design and rationale.
Trivedi MH, Claassen CA, Grannemann BD, Kashner TM, Carmody TJ, Daly E, Kern JK
Contemporary clinical trials
2007 Feb
28
192-212
Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain.
Wung JK, Perry G, Kowalski A, Harris PL, Bishop GM, Trivedi MA, Johnson SC, Smith MA, Denhardt DT, Atwood CS,
Current Alzheimer research
2007 Feb
67-72
Screening for depression in a diabetic outpatient population.
Daly EJ, Trivedi MH, Raskin P, Grannemann BG
International journal of psychiatry in clinical practice
2007
11
268-72
Treating depression complicated by comorbid medical illness or anxiety.
Trivedi MH, Clayton AH, Frank E
The Journal of clinical psychiatry
2007 Jan
68
e01
Managing depressive disorders in patients with epilepsy.
Trivedi MH, Kurian BT
Psychiatry (Edgmont (Pa. : Township))
2007 Jan
26-34
Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial.
Claassen CA, Trivedi MH, Rush AJ, Husain MM, Zisook S, Young E, Leuchter A, Wisniewski SR, Balasubramani GK, Alpert J
Journal of affective disorders
2007 Jan
97
1-3
77-84
Clinical features of depression in outpatients with and without co-occurring general medical conditions in STAR*D: confirmatory analysis.
Yates WR, Mitchell J, John Rush A, Trivedi M, Wisniewski SR, Warden D, Bryan C, Fava M, Husain MM, Gaynes BN
Primary care companion to the Journal of clinical psychiatry
2007
7-15
Item Response Analysis of the Inventory of Depressive Symptomatology.
Bernstein IH, Rush AJ, Thomas CJ, Woo A, Trivedi MH
Neuropsychiatric disease and treatment
2006 Dec
557-564
The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures.
Carmody TJ, Rush AJ, Bernstein I, Warden D, Brannan S, Burnham D, Woo A, Trivedi MH
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
2006 Dec
16
601-11
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M
The American journal of psychiatry
2006 Nov
163
11
1905-17
What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension.
Fava M, Rush AJ, Alpert JE, Carmin CN, Balasubramani GK, Wisniewski SR, Trivedi MH, Biggs MM, Shores-Wilson K
Canadian journal of psychiatry. Revue canadienne de psychiatrie
2006 Nov
51
13
823-35
Making clinicians lives easier: guidance on use of the QIDS self-report in place of the MADRS.
Carmody TJ, Rush AJ, Bernstein IH, Brannan S, Husain MM, Trivedi MH
Journal of affective disorders
2006 Oct
95
1-3
115-8
The pattern of sensory processing abnormalities in autism.
Kern JK, Trivedi MH, Garver CR, Grannemann BD, Andrews AA, Savla JS, Johnson DG, Mehta JA, Schroeder JL
Autism : the international journal of research and practice
2006 Sep
10
480-94
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
McGrath PJ, Stewart JW, Fava M, Trivedi MH, Wisniewski SR, Nierenberg AA, Thase ME, Davis L, Biggs MM, Shores-Wilson K, Luther JF, Niederehe G, Warden D, Rush AJ
The American journal of psychiatry
2006 Sep
163
1531-41; quiz 1666
Report by the ACNP Task Force on response and remission in major depressive disorder.
Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, Ninan PT, Thase ME, Gelenberg AJ, Kupfer DJ, Regier DA, Rosenbaum JF, Ray O, Schatzberg AF
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
2006 Sep
31
1841-53
Implementation of the Texas Medication Algorithm Project patient and family education program.
Toprac MG, Dennehy EB, Carmody TJ, Crismon ML, Miller AL, Trivedi MH, Suppes T, Rush AJ
The Journal of clinical psychiatry
2006 Sep
67
1362-72
Use of treatment algorithms for depression.
Trivedi MH, Fava M, Marangell LB, Osser DN, Shelton RC
The Journal of clinical psychiatry
2006 Sep
67
1458-65
A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report.
Nierenberg AA, Fava M, Trivedi MH, Wisniewski SR, Thase ME, McGrath PJ, Alpert JE, Warden D, Luther JF, Niederehe G, Lebowitz B, Shores-Wilson K, Rush AJ
The American journal of psychiatry
2006 Sep
163
1519-30; quiz 1665
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.
Fava M, Rush AJ, Wisniewski SR, Nierenberg AA, Alpert JE, McGrath PJ, Thase ME, Warden D, Biggs M, Luther JF, Niederehe G, Ritz L, Trivedi MH
The American journal of psychiatry
2006 Jul
163
1161-72
Exercise as an augmentation strategy for treatment of major depression.
Trivedi MH, Greer TL, Grannemann BD, Chambliss HO, Jordan AN
Journal of psychiatric practice
2006 Jul
12
205-13
Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR*D cohort.
Davis LL, Frazier E, Husain MM, Warden D, Trivedi M, Fava M, Cassano P, McGrath PJ, Balasubramani GK, Wisniewski SR, Rush AJ
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions
2006 Jul-Aug
15
278-85
Prevention of missing data in clinical research studies.
Wisniewski SR, Leon AC, Otto MW, Trivedi MH
Biological psychiatry
2006 Jun
59
11
997-1000
Comparison of self-report and clinician ratings on two inventories of depressive symptomatology.
Rush AJ, Carmody TJ, Ibrahim HM, Trivedi MH, Biggs MM, Shores-Wilson K, Crismon ML, Toprac MG, Kashner TM
Psychiatric services (Washington, D.C.)
2006 Jun
57
829-37
Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.
McMahon FJ, Buervenich S, Charney D, Lipsky R, Rush AJ, Wilson AF, Sorant AJ, Papanicolaou GJ, Laje G, Fava M, Trivedi MH, Wisniewski SR, Manji H
American journal of human genetics
2006 May
78
804-14
An empirical analysis of cost outcomes of the Texas Medication Algorithm Project.
Kashner TM, Rush AJ, Crismon ML, Toprac M, Carmody TJ, Miller AL, Trivedi MH, Wicker A, Suppes T
Psychiatric services (Washington, D.C.)
2006 May
57
648-59
Epidemiology of nonfatal deliberate self-harm in the United States as described in three medical databases.
Claassen CA, Trivedi MH, Shimizu I, Stewart S, Larkin GL, Litovitz T
Suicide & life-threatening behavior
2006 Apr
36
192-212
Self-rated global measure of the frequency, intensity, and burden of side effects.
Wisniewski SR, Rush AJ, Balasubramani GK, Trivedi MH, Nierenberg AA
Journal of psychiatric practice
2006 Mar
12
71-9
Medication augmentation after the failure of SSRIs for depression.
Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD, Biggs MM, Luther JF, Shores-Wilson K, Rush AJ
The New England journal of medicine
2006 Mar
354
12
1243-52
Datapoints: rates of nonfatal intentional self-harm in nine states, 2001.
Claassen CA, Trivedi MH
Psychiatric services (Washington, D.C.)
2006 Mar
57
313
Remissions in maternal depression and child psychopathology: a STAR*D-child report.
Weissman MM, Pilowsky DJ, Wickramaratne PJ, Talati A, Wisniewski SR, Fava M, Hughes CW, Garber J, Malloy E, King CA, Cerda G, Sood AB, Alpert JE, Trivedi MH, Rush AJ
JAMA : the journal of the American Medical Association
2006 Mar
295
12
1389-98
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M
The New England journal of medicine
2006 Mar
354
12
1231-42
Medication Augmentation after the Failure of SSRIs for Depression
Trivedi, M.H., Fava, M., Wisniewski, S.R., Thase, M.E., Quitkin, F., Warden, D., Ritz, L., Nierenberg, A.A., Lebowitz, B.D., Biggs, M.M., Luther, J. F., Shores-Wilson, K., Rush, A.J.
New England Journal of Medicine
Spring 2006
354
1243-52
An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.
Rush AJ, Bernstein IH, Trivedi MH, Carmody TJ, Wisniewski S, Mundt JC, Shores-Wilson K, Biggs MM, Woo A, Nierenberg AA, Fava M
Biological psychiatry
2006 Mar
59
493-501
Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
Rush, A.J., Trivedi, M.H., Wisniewski, S.R., Stewart, J.W., Nierenberg, A., Thase, M.E., Ritz, L., Biggs, M.M., Warden, D., Luther, J.F., Shores-Wilson, K., Niederehe, G., Fava, M.
New England Journal of Medicine
Spring 2006
354
1231-42
Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report.
Trivedi MH, Rush AJ, Wisniewski SR, Warden D, McKinney W, Downing M, Berman SR, Farabaugh A, Luther JF, Nierenberg AA, Callan JA, Sackeim HA
The Journal of clinical psychiatry
2006 Feb
67
185-95
TREAD: TReatment with Exercise Augmentation for Depression: study rationale and design.
Trivedi MH, Greer TL, Grannemann BD, Church TS, Galper DI, Sunderajan P, Wisniewski SR, Chambliss HO, Jordan AN, Finley C, Carmody TI
Clinical trials (London, England)
2006
291-305
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M
The American journal of psychiatry
2006 Jan
163
28-40
Exercise as an Augmentation Strategy for Treatment of Major Depression.
Trivedi, M.H., Greer, T.L., Grannemann, B.D., Chambliss, H.O., Jordan, A.N
Journal of Psychiatric Practice
2006
12(4)
205-13
Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment.
Nutt DJ, Baldwin DS, Clayton AH, Elgie R, Lecrubier Y, Montejo AL, Papakostas GI, Souery D, Trivedi MH, Tylee A
The Journal of clinical psychiatry
2006
67 Suppl 6
46-9
Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice
Trivedi, M.H., Rush, A.J., Wisniewski, S.R., Nierenberg, A.A., Warden, D., Ritz, L, Norquist, G., Howland, R.H., McGrath, P.J., Shores-Wilson, K., Biggs, M.M., Balasubramani, G.K., Fava, M.
The American Journal of Psychiatry
2006
163(1)
28-40
Major depressive disorder: remission of associated symptoms.
Trivedi MH
The Journal of clinical psychiatry
2006
67 Suppl 6
27-32
Factors Associated with Health-Related Quality of Life Among Outpatients with Major Depressive Disorder: A STARD Report.
Trivedi, M.H., Rush, A.J., Wisniewski, S.R., Warden, D., McKinney, W., Downing, M., Berman, S.R., Farabaugh, A., Luther, J., Nierenberg, A.A., Lis, J., Sackeim, H.
The Journal of Clinical Psychiatry
2006
67(2)
185-95.
Inverse association between physical inactivity and mental health in men and women.
Galper DI, Trivedi MH, Barlow CE, Dunn AL, Kampert JB
Medicine and science in sports and exercise
2006 Jan
38
173-8
Treatment-resistant depression.
Souery D, Papakostas GI, Trivedi MH
The Journal of clinical psychiatry
2006
67 Suppl 6
16-22
Recent Advances in the Treatment of Depression in the Presence of Physical Symptoms
Trivedi, M.H., Katon, W.J., Daly, E., Clayton, A.H., Frank, E.
The Journal of Clinical Psychiatry
2006
67(2)
310-21
Children of currently depressed mothers: a STAR*D ancillary study.
Pilowsky DJ, Wickramaratne PJ, Rush AJ, Hughes CW, Garber J, Malloy E, King CA, Cerda G, Sood AB, Alpert JE, Wisniewski SR, Trivedi MH, Talati A, Carlson MM, Liu HH, Fava M, Weissman MM
The Journal of clinical psychiatry
2006 Jan
67
126-36
Use of Treatment Algorithms for Depression
Trivedi, M.H., Fava, M., Marangell, L.B., Osser, D.N., Shelton, R.C.
Journal of Clinical Psychiatry
2006
67(9)
1458-65
Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project.
Dennehy EB, Suppes T, Rush AJ, Miller AL, Trivedi MH, Crismon ML, Carmody TJ, Kashner TM
Psychological medicine
2005 Dec
35
12
1695-706
Response to Zhang et al. (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 11-16.
Zhou Z, Peters EJ, Hamilton SP, McMahon F, Thomas C, McGrath PJ, Rush J, Trivedi MH, Charney DS, Roy A, Wisniewski S, Lipsky R, Goldman D
Neuron
2005 Dec
48
702-3; author reply 705-6
Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project.
Gilmer WS, Trivedi MH, Rush AJ, Wisniewski SR, Luther J, Howland RH, Yohanna D, Khan A, Alpert J
Acta psychiatrica Scandinavica
2005 Dec
112
425-33
Assessing insomnia severity in depression: comparison of depression rating scales and sleep diaries.
Manber R, Blasey C, Arnow B, Markowitz JC, Thase ME, Rush AJ, Dowling F, Koscis J, Trivedi M, Keller MB,
Journal of psychiatric research
2005 Sep
39
481-8
Gender differences in depression: findings from the STAR*D study.
Marcus SM, Young EA, Kerber KB, Kornstein S, Farabaugh AH, Mitchell J, Wisniewski SR, Balasubramani GK, Trivedi MH, Rush AJ
Journal of affective disorders
2005 Aug
87
2-3
141-50
Characteristics of insured and noninsured outpatients with depression in STAR(*)D.
Lesser IM, Leuchter AF, Trivedi MH, Davis LL, Wisniewski SR, Balasubramani GK, Petersen T, Stegman D, Rush AJ
Psychiatric services (Washington, D.C.)
2005 Aug
56
995-1004
Symptom clusters as predictors of late response to antidepressant treatment.
Trivedi MH, Morris DW, Grannemann BD, Mahadi S
The Journal of clinical psychiatry
2005 Aug
66
1064-70
Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features.
Rush AJ, Zimmerman M, Wisniewski SR, Fava M, Hollon SD, Warden D, Biggs MM, Shores-Wilson K, Shelton RC, Luther JF, Thomas B, Trivedi MH
Journal of affective disorders
2005 Jul
87
43-55
Impaired delay and trace eyeblink conditioning performance in major depressive disorder.
Greer TL, Trivedi MH, Thompson LT
Journal of affective disorders
2005 Jun
86
2-3
235-45
Brief psychiatric rating scale expanded version: How do new items affect factor structure?
Velligan D, Prihoda T, Dennehy E, Biggs M, Shores-Wilson K, Crismon ML, Rush AJ, Miller A, Suppes T, Trivedi M, Kashner TM, Witte B, Toprac M, Carmody T, Chiles J, Shon S,
Psychiatry research
2005 Jun
135
217-28
Depression and pain: implications for symptomatic presentation and pharmacological treatments.
Kleiber B, Jain S, Trivedi MH
Psychiatry (Edgmont (Pa. : Township))
2005 May
12-8
Self-reported premenstrual exacerbation of depressive symptoms in patients seeking treatment for major depression.
Kornstein SG, Harvey AT, Rush AJ, Wisniewski SR, Trivedi MH, Svikis DS, McKenzie ND, Bryan C, Harley R
Psychological medicine
2005 May
35
683-92
Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
Schatzberg AF, Rush AJ, Arnow BA, Banks PL, Blalock JA, Borian FE, Howland R, Klein DN, Kocsis JH, Kornstein SG, Manber R, Markowitz JC, Miller I, Ninan PT, Rothbaum BO, Thase ME, Trivedi MH, Keller MB
Archives of general psychiatry
2005 May
62
513-20
Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment?
Hollon SD, Jarrett RB, Nierenberg AA, Thase ME, Trivedi M, Rush AJ
The Journal of clinical psychiatry
2005 Apr
66
455-68
What moderator characteristics are associated with better prognosis for depression?
Trivedi MH, Morris DW, Pan JY, Grannemann BD, John Rush A
Neuropsychiatric disease and treatment
2005 Mar
51-7
A direct comparison of presenting characteristics of depressed outpatients from primary vs. specialty care settings: preliminary findings from the STAR*D clinical trial.
Gaynes BN, Rush AJ, Trivedi M, Wisniewski SR, Balasubramani GK, Spencer DC, Petersen T, Klinkman M, Warden D, Schneider RK, Castro DB, Golden RN,
General hospital psychiatry
2005 Mar-Apr
27
87-96
Prevalence and clinical correlates of irritability in major depressive disorder: a preliminary report from the Sequenced Treatment Alternatives to Relieve Depression study.
Perlis RH, Fraguas R, Fava M, Trivedi MH, Luther JF, Wisniewski SR, Rush AJ
The Journal of clinical psychiatry
2005 Feb
66
159-66; quiz 147, 273-4
Quality improvement methods as applied to a multicenter effectiveness trial--STAR*D.
Warden D, Rush AJ, Trivedi M, Ritz L, Stegman D, Wisniewski SR,
Contemporary clinical trials
2005 Feb
26
95-112
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients.
Rush AJ, Trivedi MH, Carmody TJ, Ibrahim HM, Markowitz JC, Keitner GI, Kornstein SG, Arnow B, Klein DN, Manber R, Dunner DL, Gelenberg AJ, Kocsis JH, Nemeroff CB, Fawcett J, Thase ME, Russell JM, Jody DN, Borian FE, Keller MB
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
2005 Feb
30
405-16
Exercise treatment for depression: efficacy and dose response.
Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO
American journal of preventive medicine
2005 Jan
28
1-8
Factors that differentiate early vs. later onset of major depression disorder.
Zisook S, Rush AJ, Albala A, Alpert J, Balasubramani GK, Fava M, Husain M, Sackeim H, Trivedi M, Wisniewski S
Psychiatry research
2004 Dec
129
127-40
Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D.
Yates WR, Mitchell J, Rush AJ, Trivedi MH, Wisniewski SR, Warden D, Hauger RB, Fava M, Gaynes BN, Husain MM, Bryan C
General hospital psychiatry
2004 Nov-Dec
26
421-9
Suicide risk management for the sequenced treatment alternatives to relieve depression study: applied NIMH guidelines.
Nierenberg AA, Trivedi MH, Ritz L, Burroughs D, Greist J, Sackeim H, Kornstein S, Schwartz T, Stegman D, Fava M, Wisniewski SR
Journal of psychiatric research
2004 Nov-Dec
38
583-9
Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D.
Fava M, Alpert JE, Carmin CN, Wisniewski SR, Trivedi MH, Biggs MM, Shores-Wilson K, Morgan D, Schwartz T, Balasubramani GK, Rush AJ
Psychological medicine
2004 Oct
34
1299-308
Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder.
Trivedi MH, Wan GJ, Mallick R, Chen J, Casciano R, Geissler EC, Panish JM
Journal of clinical psychopharmacology
2004 Oct
24
497-506
Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.
Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD
The Journal of clinical psychiatry
2004 Oct
65
10
1356-64
Reductions in stress and depressive symptoms in mothers of substance-exposed infants, participating in a psychosocial program.
Kern JK, West EY, Grannemann BD, Greer TL, Snell LM, Cline LL, VanBeveren TT, Heartwell SF, Kleiber BA, Trivedi MH
Maternal and child health journal
2004 Sep
127-36
Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression.
Klein DN, Santiago NJ, Vivian D, Blalock JA, Kocsis JH, Markowitz JC, McCullough Jr JP, Rush AJ, Trivedi MH, Arnow BA, Dunner DL, Manber R, Rothbaum B, Thase ME, Keitner GI, Miller IW, Keller MB
Journal of consulting and clinical psychology
2004 Aug
72
681-8
A computerized clinical decision support system as a means of implementing depression guidelines.
Trivedi MH, Kern JK, Grannemann BD, Altshuler KZ, Sunderajan P
Psychiatric services (Washington, D.C.)
2004 Aug
55
879-85
One-year clinical outcomes of depressed public sector outpatients: a benchmark for subsequent studies.
Rush AJ, Trivedi M, Carmody TJ, Biggs MM, Shores-Wilson K, Ibrahim H, Crismon ML
Biological psychiatry
2004 Jul
56
46-53
Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project.
Trivedi MH, Rush AJ, Crismon ML, Kashner TM, Toprac MG, Carmody TJ, Key T, Biggs MM, Shores-Wilson K, Witte B, Suppes T, Miller AL, Altshuler KZ, Shon SP
Archives of general psychiatry
2004 Jul
61
669-80
Clinicians' adherence to an algorithm for pharmacotherapy of depression in the Texas public mental health sector.
Bettinger TL, Crismon ML, Trivedi MH, Grannemann B, Shon SP
Psychiatric services (Washington, D.C.)
2004 Jun
55
703-5
Methods of testing feasibility for sequenced treatment alternatives to relieve depression (STAR*D).
Wisniewski SR, Stegman D, Trivedi M, Husain MM, Eng H, Shores-Wilson K, Luther J, Biggs MM, Burroughs D, Ritz AL, Fava M, Quitkin F, Rush AJ
Journal of psychiatric research
2004 May-Jun
38
241-8
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.
Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, Thase ME, Nierenberg AA, Quitkin FM, Kashner TM, Kupfer DJ, Rosenbaum JF, Alpert J, Stewart JW, McGrath PJ, Biggs MM, Shores-Wilson K, Lebowitz BD, Ritz L, Niederehe G
Controlled clinical trials
2004 Feb
25
119-42
The effectiveness of secretin in the management of autism.
Kern JK, Espinoza E, Trivedi MH
Expert opinion on pharmacotherapy
2004 Feb
379-87
The Texas Medication Algorithm Project (TMAP): Clinical Results for Patients with Major Depressive Disorder
Trivedi, M.H., Rush, A.J., Crismon, M.L., Kashner, T.M., Toprac, M.G., Carmody, T.J., Key, T., Biggs, N.M., Shores-Wilson, K., Witte, B, Suppes, T., Miller, A.L., Altshuler, K.Z., and Shon, S.P.
Archives of General Psychiatry
2004
61(7)
669-680
Web-based communications and management of a multi-center clinical trial: the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project.
Wisniewski SR, Eng H, Meloro L, Gatt R, Ritz L, Stegman D, Trivedi M, Biggs MM, Friedman E, Shores-Wilson K, Warden D, Bartolowits D, Martin JP, Rush AJ
Clinical trials (London, England)
2004
387-98
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation.
Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, Crismon ML, Shores-Wilson K, Toprac MG, Dennehy EB, Witte B, Kashner TM
Psychological medicine
2004 Jan
34
73-82
The Texas medication algorithm project: clinical results for schizophrenia.
Miller AL, Crismon ML, Rush AJ, Chiles J, Kashner TM, Toprac M, Carmody T, Biggs M, Shores-Wilson K, Chiles J, Witte B, Bow-Thomas C, Velligan DI, Trivedi M, Suppes T, Shon S
Schizophrenia bulletin
2004
30
627-47
The link between depression and physical symptoms.
Trivedi MH
Primary care companion to the Journal of clinical psychiatry
2004
Suppl 1
12-6
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
Gelenberg AJ, Trivedi MH, Rush AJ, Thase ME, Howland R, Klein DN, Kornstein SG, Dunner DL, Markowitz JC, Hirschfeld RM, Keitner GI, Zajecka J, Kocsis JH, Russell JM, Miller I, Manber R, Arnow B, Rothbaum B, Munsaka M, Banks P, Borian FE, Keller MB
Biological psychiatry
2003 Oct
54
806-17
The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.
Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB
Biological psychiatry
2003 Sep
54
573-83
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.
Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA, Quitkin FM, Wisniewski S, Lavori PW, Rosenbaum JF, Kupfer DJ
The Psychiatric clinics of North America
2003 Jun
26
457-94, x
Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design.
Rush AJ, Crismon ML, Kashner TM, Toprac MG, Carmody TJ, Trivedi MH, Suppes T, Miller AL, Biggs MM, Shores-Wilson K, Witte BP, Shon SP, Rago WV, Altshuler KZ
The Journal of clinical psychiatry
2003 Apr
64
357-69
Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania.
Suppes T, Rush AJ, Dennehy EB, Crismon ML, Kashner TM, Toprac MG, Carmody TJ, Brown ES, Biggs MM, Shores-Wilson K, Witte BP, Trivedi MH, Miller AL, Altshuler KZ, Shon SP
The Journal of clinical psychiatry
2003 Apr
64
370-82
Treatment-resistant depression: new therapies on the horizon.
Trivedi MH
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists
2003 Mar
15
59-70
The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression.
Manber R, Rush AJ, Thase ME, Amow B, Klein D, Trivedi MH, Korenstein SG, Markowitz JC, Dunner DL, Munsaka M, Borian FE, Martin null, Keller B
Sleep
2003 Mar
26
130-6
Catching up on health outcomes: the Texas Medication Algorithm Project.
Kashner TM, Carmody TJ, Suppes T, Rush AJ, Crismon ML, Miller AL, Toprac M, Trivedi M
Health services research
2003 Feb
38
1 Pt 1
311-31
Depression, IV: STAR*D treatment trial for depression.
Rush AJ, Trivedi M, Fava M,
The American journal of psychiatry
2003 Feb
160
237
Using treatment algorithms to bring patients to remission.
Trivedi MH
The Journal of clinical psychiatry
2003
64 Suppl 2
8-13
Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
Kocsis JH, Rush AJ, Markowitz JC, Borian FE, Dunner DL, Koran LM, Klein DN, Trivedi MH, Arnow B, Keitner G, Kornstein SG, Keller MB
Psychopharmacology bulletin
2003
37
73-87
Remission of depression and the Texas Medication Algorithm Project.
Trivedi MH
Managed care interface
2003
Suppl B
9-13
The DOSE study: a clinical trial to examine efficacy and dose response of exercise as treatment for depression.
Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO
Controlled clinical trials
2002 Oct
23
584-603
Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination.
Zajecka J, Dunner DL, Gelenberg AJ, Hirschfeld RM, Kornstein SG, Ninan PT, Rush AJ, Thase ME, Trivedi MH, Arnow BA, Borian FE, Manber R, Keller MB
The Journal of clinical psychiatry
2002 Aug
63
709-16
Efficacy of porcine secretin in children with autism and pervasive developmental disorder.
Kern JK, Van Miller S, Evans PA, Trivedi MH
Journal of autism and developmental disorders
2002 Jun
32
153-60
Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression.
Thase ME, Rush AJ, Manber R, Kornstein SG, Klein DN, Markowitz JC, Ninan PT, Friedman ES, Dunner DL, Schatzberg AF, Borian FE, Trivedi MH, Keller MB
The Journal of clinical psychiatry
2002 Jun
63
493-500
Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
Ninan PT, Rush AJ, Crits-Christoph P, Kornstein SG, Manber R, Thase ME, Trivedi MH, Rothbaum BO, Zajecka J, Borian FE, Keller MB
The Journal of clinical psychiatry
2002 May
63
434-41
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination.
Hirschfeld RM, Dunner DL, Keitner G, Klein DN, Koran LM, Kornstein SG, Markowitz JC, Miller I, Nemeroff CB, Ninan PT, Rush AJ, Schatzberg AF, Thase ME, Trivedi MH, Borian FE, Crits-Christoph P, Keller MB
Biological psychiatry
2002 Jan
51
123-33
Optimizing treatment outcomes for patients with depression and generalized anxiety disorder.
Thase ME, Trivedi M,
Psychopharmacology bulletin
2002
36 Suppl 2
93-102
Quantitative EEG amplitude across REM sleep periods in depression: preliminary report.
Liscombe MP, Hoffmann RF, Trivedi MH, Parker MK, Rush AJ, Armitage R
Journal of psychiatry & neuroscience : JPN
2002 Jan
27
40-6
Algorithms in clinical psychiatry: a stepped approach toward the path to recovery.
Trivedi M,
Psychopharmacology bulletin
2002
36 Suppl 2
142-9
Development and implementation of computerized clinical guidelines: barriers and solutions.
Trivedi MH, Kern JK, Marcee A, Grannemann B, Kleiber B, Bettinger T, Altshuler KZ, McClelland A
Methods of information in medicine
2002
41
435-42
Strengthening clinical effectiveness trials: equipoise-stratified randomization.
Lavori PW, Rush AJ, Wisniewski SR, Alpert J, Fava M, Kupfer DJ, Nierenberg A, Quitkin FM, Sackeim HA, Thase ME, Trivedi M,
Biological psychiatry
2001 Nov
50
10
792-801
Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients?
Trivedi MH, Rush AJ, Carmody TJ, Donahue RM, Bolden-Watson C, Houser TL, Metz A
The Journal of clinical psychiatry
2001 Oct
62
10
776-81
Occipital brain perfusion deficits in children with major depressive disorder.
Bonte FJ, Trivedi MH, Devous MD, Harris TS, Payne JK, Weinberg WA, Haley RW
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
2001 Jul
42
1059-61
Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline.
Rush AJ, Trivedi MH, Carmody TJ, Donahue RM, Houser TL, Bolden-Watson C, Batey SR, Ascher JA, Metz A
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
2001 Jul
25
131-8
Physical activity dose-response effects on outcomes of depression and anxiety.
Dunn AL, Trivedi MH, O'Neal HA
Medicine and science in sports and exercise
2001 Jun
33
6 Suppl
S587-97; discussion 609-10
Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.
Fava M, Dunner DL, Greist JH, Preskorn SH, Trivedi MH, Zajecka J, Cohen M
The Journal of clinical psychiatry
2001 Jun
62
413-20
Regional cerebral blood flow response to oral amphetamine challenge in healthy volunteers.
Devous MD, Trivedi MH, Rush AJ
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
2001 Apr
42
535-42
Which depressed patients respond to nefazodone and when?
Trivedi MH, Rush AJ, Pan JY, Carmody TJ
The Journal of clinical psychiatry
2001 Mar
62
158-63
Which Depressed Patients Respond to Nefazodone and When?
Trivedi MH, Rush AJ, Pan Ji-Yang, Carmody TJ.
Journal of Clinical Psychiatry
2001
62(3)
158-163
Algorithm for the treatment of chronic depression.
Trivedi MH, Kleiber BA
The Journal of clinical psychiatry
2001
62 Suppl 6
22-9
Clinical significance of monitoring early symptom change to predict outcome.
Trivedi MH, Baker SM
The Journal of clinical psychiatry
2001
62 Suppl 4
27-33; discussion 37-40
Sensitizing clinicians and patients to the social and functional aspects of remission.
Trivedi MH
The Journal of clinical psychiatry
2001
62 Suppl 19
32-5
An ideal trial to test differential onset of antidepressant effect.
Leon AC, Blier P, Culpepper L, Gorman JM, Hirschfeld RM, Nierenberg AA, Roose SP, Rosenbaum JF, Stahl SM, Trivedi MH
The Journal of clinical psychiatry
2001
62 Suppl 4
34-6; discussion 37-40
Do Bupropion SR and Sertraline Differ in Their Effects on Anxiety in Depressed Patients
Trivedi MH, Rush AJ, Carmody TJ, Donahue RMJ, Bolden-Watson C, Houser TL, Metz A.
Journal of Clinical Psychiatry
2001
62(10)
776-781
Using treatment algorithms for the effective management of treatment-resistant depression.
Trivedi MH, Kleiber BA
The Journal of clinical psychiatry
2001
62 Suppl 18
25-9
Computerizing medication algorithms and decision support systems for major psychiatric disorders.
Trivedi MH, Kern JK, Baker SM, Altshuler KZ
Journal of psychiatric practice
2000 Sep
237-46
Slow-wave activity in NREM sleep: sex and age effects in depressed outpatients and healthy controls.
Armitage R, Hoffmann R, Trivedi M, Rush AJ,
Psychiatry research
2000 Sep
95
201-13
Temporal characteristics of delta activity during NREM sleep in depressed outpatients and healthy adults: group and sex effects.
Armitage R, Hoffmann R, Fitch T, Trivedi M, Rush AJ,
Sleep
2000 Aug
23
607-17
Evaluation of newer treatment interventions for psychotic depression.
O'Neal BL, Smith CL, Trivedi M
Current psychiatry reports
2000 Aug
305-9
A comparison of alternative assessments of depressive symptom severity: a pilot study.
Biggs MM, Shores-Wilson K, Rush AJ, Carmody TJ, Trivedi MH, Crismon ML, Toprac MG, Mason M, Biggs MM
Psychiatry research
2000 Jul
95
55-65
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.
Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, Markowitz JC, Nemeroff CB, Russell JM, Thase ME, Trivedi MH, Zajecka J
The New England journal of medicine
2000 May
342
20
1462-70
High grade, synchronous colon cancers after renal transplantation: were immunosuppressive drugs to blame?
Trivedi MH, Agrawal S, Muscato MS, Metzler MH, Marshall JB
The American journal of gastroenterology
1999 Nov
94
11
3359-61
The Texas Children's Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder.
Hughes CW, Emslie GJ, Crismon ML, Wagner KD, Birmaher B, Geller B, Pliszka SR, Ryan ND, Strober M, Trivedi MH, Toprac MG, Sedillo A, Llana ME, Lopez M, Rush AJ
Journal of the American Academy of Child and Adolescent Psychiatry
1999 Nov
38
11
1442-54
Anaplastic and sarcomatoid carcinoma of the small intestine: an unusual tumor.
Agrawal S, Trivedi MH, Lukens FJ, Moon C, Ingram EA, Barthel JS
Journal of clinical gastroenterology
1999 Jul
29
99-101
Effects of fluoxetine on the polysomnogram in outpatients with major depression.
Trivedi MH, Rush AJ, Armitage R, Gullion CM, Grannemann BD, Orsulak PJ, Roffwarg HP
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
1999 May
20
447-59
Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project.
Rush AJ, Rago WV, Crismon ML, Toprac MG, Shon SP, Suppes T, Miller AL, Trivedi MH, Swann AC, Biggs MM, Shores-Wilson K, Kashner TM, Pigott T, Chiles JA, Gilbert DA, Altshuler KZ
The Journal of clinical psychiatry
1999 May
60
284-91
A SPECT HMPAO study of regional cerebral blood flow in depressed adolescents and normal controls.
Kowatch RA, Devous MD, Harvey DC, Mayes TL, Trivedi MH, Emslie GJ, Weinberg WA
Progress in neuro-psychopharmacology & biological psychiatry
1999 May
23
643-56
Treatment of depression--newer pharmacotherapies.
Mulrow CD, Williams JW, Trivedi M, Chiquette E, Aguilar C, Cornell JE, Badgett R, Noel PH, Lawrence V, Lee S, Luther M, Ramirez G, Richardson WS, Stamm K,
Evidence report/technology assessment (Summary)
1999 Mar
1-4
Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression.
Lotufo-Neto F, Trivedi M, Thase ME,
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
1999 Mar
20
226-47
The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder.
Crismon ML, Trivedi M, Pigott TA, Rush AJ, Hirschfeld RM, Kahn DA, DeBattista C, Nelson JC, Nierenberg AA, Sackeim HA, Thase ME,
The Journal of clinical psychiatry
1999 Mar
60
142-56
Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression.
Feiger AD, Bielski RJ, Bremner J, Heiser JF, Trivedi M, Wilcox CS, Roberts DL, Kensler TT, McQuade RD, Kaplita SB, Archibald DG,
International clinical psychopharmacology
1999 Jan
14
19-28
Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group.
Vivino FB, Al-Hashimi I, Khan Z, LeVeque FG, Salisbury PL, Tran-Johnson TK, Muscoplat CC, Trivedi M, Goldlust B, Gallagher SC
Archives of internal medicine
1999 Jan
159
174-81
A Spect HMPAO Study of Regional Cerebral Bloodflow in Depressed Adolescents and Normal Controls
Michael D.Devous Sr. ROBERT A. KOWATCH, DONALD C. HARVEY, TARYN L. MAYES, MADHUKAR H. TRIVEDI, GRAHAM J. EMSLIE and W. A. WEINBERG
Progress in Neuro-Psychopharmacology and Biological Psychiatry
1999
23
643-656
Mental health care from the public perspective: the Texas Medication Algorithm Project.
Shon SP, Crismon ML, Toprac MG, Trivedi M, Miller AL, Suppes T, Rush AJ
The Journal of clinical psychiatry
1999
60 Suppl 3
16-20; discussion 21
Developing treatment algorithms for unipolar depression in Cyberspace: International Psychopharmacology Algorithm Project (IPAP).
Trivedi MH, DeBattista C, Fawcett J, Nelson C, Osser DN, Stein D, Jobson K
Psychopharmacology bulletin
1998
34
355-9
Consensus guidelines in the treatment of major depressive disorder.
Rush AJ, Crismon ML, Toprac MG, Trivedi MH, Rago WV, Shon S, Altshuler KZ
The Journal of clinical psychiatry
1998
59 Suppl 20
73-84
Treatment of depression--newer pharmacotherapies.
Mulrow CD, Williams JW, Trivedi M, Chiquette E, Aguilar C, Cornell JE, Badgett R, Noël PH, Lawrence V, Lee S, Luther M, Ramirez G, Richardson WS, Stamm K,
Psychopharmacology bulletin
1998
34
409-795
Growth hormone response to the GABAB agonist baclofen in major depressive disorder.
Davis LL, Trivedi M, Choate A, Kramer GL, Petty F,
Psychoneuroendocrinology
1997 Apr
22
129-40
The psychopharmacological treatment of nonmajor mood disorders.
Yonkers KA, Clark RH, Trivedi MH
Modern problems of pharmacopsychiatry
1997
25
146-66
Relationship between objective and subjective sleep measures in depressed patients and healthy controls.
Armitage R, Trivedi M, Hoffmann R, Rush AJ,
Depression and anxiety
1997
97-102
Comparison of technetium-99m-HMPAO and xenon-133 measurements of regional cerebral blood flow by SPECT.
Payne JK, Trivedi MH, Devous MD
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
1996 Oct
37
10
1735-40
The Inventory of Depressive Symptomatology (IDS): psychometric properties.
Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH
Psychological medicine
1996 May
26
477-86
Functional neuroanatomy of obsessive-compulsive disorder.
Trivedi MH
The Journal of clinical psychiatry
1996
57 Suppl 8
26-35; discussion 36
Benzodiazepines as antidepressants: does GABA play a role in depression?
Petty F, Trivedi MH, Fulton M, Rush AJ
Biological psychiatry
1995 Nov
38
578-91
MAOIs in the contemporary treatment of depression.
Thase ME, Trivedi MH, Rush AJ
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
1995 May
12
185-219
Sex differences in the distribution of EEG frequencies during sleep: unipolar depressed outpatients.
Armitage R, Hudson A, Trivedi M, Rush AJ,
Journal of affective disorders
1995 May
34
121-9
Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications?
Trivedi MH, Rush H
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
1994 Aug
11
33-43
Congestive gastropathy: factors influencing development, endoscopic features, Helicobacter pylori infection, and microvessel changes.
Parikh SS, Desai SB, Prabhu SR, Trivedi MH, Shankaran K, Bhukhanwala FA, Kalro RH, Desai HG
The American journal of gastroenterology
1994 Jul
89
1036-42
The effects of nefazodone on sleep architecture in depression.
Armitage R, Rush AJ, Trivedi M, Cain J, Roffwarg HP,
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
1994 Apr
10
123-7
Guidelines for the diagnosis and treatment of depression for primary care physicians. Implications for consultation-liaison psychiatrists.
Kathol R, Katon W, Smith GR, Petty F, Trivedi M, Rush AJ,
Psychosomatics
1994 Jan-Feb
35
1-12
Regional cerebral blood flow alterations in unipolar depression.
Devous MD, Gullion CM, Grannemann BD, Trivedi MH, Rush AJ
Psychiatry research
1993 Dec
50
233-56
The development of clinical practice guidelines for the diagnosis and treatment of depression.
Rush AJ, Trivedi M, Schriger D, Petty F,
General hospital psychiatry
1992 Jul
14
230-6
[As others see us].
Telnes L, Van Gaalen J, Albrecht J,
L' Infirmiere canadienne
1967 Jan
26-30
Research
Evidence based psychopharmacology and treatment algorithms in Mood Disorders
Functional Brain Imaging in Major Depressive and Obsessive Compulsive Disorders
Neurobiology and Psychopharmacology of Depression and Bipolar Disorder
Links
Trivedi Lab
Center for Depression Research and Clinical Care
Department of Psychiatry
Articles by Dr. Trivedi
Brain
Mental Health
Breakthroughs in depression research lead to more effective treatments
Madhukar Trivedi, M.D.
December 9, 2020
Brain
Mental Health
The Depression Test
Madhukar Trivedi, M.D.
November 9, 2018
Brain
The Kids Are All Right
Madhukar Trivedi, M.D.
November 9, 2018
Brain
Can we diagnose and treat depression faster?
Madhukar Trivedi, M.D.
July 6, 2017
More Articles
Share:
email